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Dear Ministers,
Although the treatment of childhood leukaemia has made progress in recent 
decades, the occurrence of this serious disease tends to raise concerns about the 
possibility of environmental causes. An extensive evaluation of the scientific 
knowledge shows in general limited evidence for causal relations with specific 
environmental factors. The disease occurs through a complex interplay of genetic 
susceptibilities and different environmental factors that is hard to unravel.
This is the main conclusion of the advisory report that we are pleased to present 
to you. It has been drafted by a joint Committee of the Belgian Superior Health 
Council and the Health Council of the Netherlands, and has been reviewed by 
experts connected to both councils as well as by experts from the European 
Science Advisory Network for Health (EuSANH).
In the last decade of the 20th century the incidence of childhood leukaemia has 
shown an increase, raising the question what role environmental exposures have 
played in this. The trend now seems to have been stopped or even reversed, but 
there are still approximately 80 new cases of childhood leukaemia per year in 
Belgium and about 140 new cases in the Netherlands. 
The possibilities to reduce these numbers are limited, since few environmental 
factors could be identified as contributors. Most cases of childhood leukaemia 
simply cannot be prevented. The report does, however, suggest a few protective 
measures and health recommendations, given the available evidence and the 
importance of a precautionary approach when much is still uncertain. The 
application of precautionary measures is required more in the case of some 
factors than in others, depending on, among other considerations, what is known. Health Council
of the Netherlands
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Date : December 6, 2012In view of the relatively small numbers of cases of childhood leukaemia per 
country, the councils recommend international cooperation in studying variations 
in the incidence of childhood leukaemia and their possible relations to different 
environmental exposures. Cooperation is also recommended in studying possible 
interactions between different agents and genetic subtypes linked to the onset of 
childhood leukaemia.
This is the first advisory report that is the result of a collaborative effort within 
the framework of EuSANH. Both councils hope it will not prove to be unique. 
The collaboration has resulted in an evaluation of the scientific evidence that is 
fully agreed upon by the two health councils.
One of the goals of EuSANH is to provide science based policy advice that 
transcends national boundaries, in order to prevent duplication of work and to 
arrive at shared insights. This will not only have financial benefits, but also 
provide a more solid basis for national and international policies. It is our hope 
that this report will help to realise these aims.
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Executive Summary
Childhood leukaemia is a cancer that affects the blood forming system in the 
body. The disease is caused by a complex interplay of genetic, natural and man-
made environmental factors. In Belgium, the Netherlands and other 
Northwestern European countries each year about 5 in 100,000 children are 
confronted with this serious condition, which requires intensive treatment. In 
recent years the average number of new cases per year was approximately 80 in 
Belgium and 140 in the Netherlands.
Most young patients have a lymphoid type of acute leukaemia, ALL. A 
smaller percentage is affected by an acute myeloid manifestation of the disease, 
AML. Due to the improvements in care and treatment in recent decades in 
Western-European countries, about 85% of children with ALL and about 60% of 
children with AML survive the first five years after they have been diagnosed.
In the last decade of the 20th century the occurrence of childhood leukaemia 
has shown a rise. The question arose whether this could be attributed to an 
increased exposure to risk factors. Although this trend now seems to have been 
stopped or even reversed, there is still every reason to get more clarity on the role 
of environmental factors in the induction and development of childhood 
leukaemia. 
It is the aim of this report, drawn up by a joint Committee of the Belgian 
Superior Health Council and the Health Council of the Netherlands, to do just 
that. The Committee has taken a precautionary perspective to guide its evaluation 
of scientific knowledge and recommendations. 
Evidence on the impact of environmental factors
The complex interplay of genetic abnormalities and natural and man-made 
environmental exposures makes it hard to establish the role of separate factors. 
Based on current knowledge, the most important conclusions are that the 
majority of leukaemia cases cannot be explained and only a small fraction of 
cases might be prevented. Those are addressed in this report.
Only where ionising radiation is concerned, a causal relation with childhood 
leukaemia has been established. Exposure to this type of radiation occurs 
naturally, but also through medical applications such as X-rays and in particular 
CT-scans.
For exposure to benzene and tobacco smoking of fathers a causal relationship 
with childhood leukaemia is deemed likely, given the available evidence. A Executive Summary 11
relation with pesticides is labelled ‘possible to likely’. Two protective influences 
are also considered likely: breast feeding and day-care attendance or other 
contacts between young children.
For the majority of physical, chemical and other environmental factors under 
study, the likelihood of a causal relation with the onset of childhood leukaemia 
could only be labelled as ‘possible’, ‘uncertain’ or ‘unknown’.
Recommended measures
In view of the findings in this report, the Committee advocates to complement 
the traditional anti-microbial hygiene with ‘physical-chemical hygiene’, aiming 
to limiting environmental exposures to possibly harmful agents as much as 
feasible. 
Given the tentative nature of much of the scientific knowledge and the 
limited possibilities to reduce the role of naturally occurring exposures, only a 
limited array of measures are (as yet) available to limit possibly harmful 
exposures or to utilise protective opportunities. In this, a balance needs to be 
struck between sufficient precaution and being overly careful.
Some principles are, however, clear. The median age for the onset of 
childhood leukaemia is around five. To be effective, measures will therefore have 
to be primarily aimed at pre-school children, infants, pregnant women and 
women (and their partners) intending to conceive. The Committee recommends 
that women of childbearing age should be counselled, in order to create 
awareness of the risk of certain environmental and lifestyle factors previous to an 
intended conception. Furthermore, with this much still uncertain, it makes sense 
to suggest measures that are in accordance with policies and guidelines that have 
already been implemented to protect against other diseases or risks.
Within these parameters, a number of recommendations can be given:
• Priority should be given to reducing the exposure to ionising radiation for 
medical purposes in the case of pregnant women and young children. More 
risk awareness among professionals in choosing diagnostic methods can 
achieve this.
• Although a causal relation with the currently used exposures to ultrasound 
scans that are routinely made during pregnancy is considered unlikely, 
ultrasound scans should not be offered without medical indication, to limit 
exposure.
• An important measure is the reduction of exposure to pesticides, especially 
for pregnant women who may be exposed in the work place or at home, and 
for women who wish to conceive. They should refrain from working with 
pesticides, or use extra protective measures.
• Since smoking (both of tobacco and marijuana) and alcohol use by parents 
are known to be able to contribute to several adverse health effects in 12 Childhood leukaemia and environmental factors
children, guidelines regarding these lifestyle factors are already in place. 
Although a causal relation with childhood leukaemia has not been 
established, the possibility of such a relation may give extra credence to the 
current advice to refrain from these activities, especially while trying to 
conceive and during pregnancy.
• It is also advisable, given the possibility of a causal relation with childhood 
leukaemia, for pregnant women to avoid nitrite-cured meat, such as ham, 
bacon and sausages. 
• Finally, the existing recommendation to breast-feed up to the age of six 
months, whenever it is feasible to do so, is reinforced by the likelihood that 
breast feeding may also protect against childhood leukaemia.
A need for further knowledge
Although more knowledge has been emerging, many things about the 
environmental causes of childhood leukaemia are as yet uncertain or only 
tentatively understood. The findings in this report, however, clearly indicate 
where further research is most needed. 
Since the numbers of patients per country are often too small to establish 
relationships between causes and effects, international studies on the incidence 
of childhood leukaemia and its relation to environmental factors are required. At 
the same time, research into specific factors, particularly the adverse effects of 
frequent ultrasounds and the use of pesticides, need to be carried out. In addition, 
research is needed into the accumulation of risks due to combined exposures, 
since this subject has so far hardly been explored.Executive Summary 13
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Samenvatting
Leukemie bij kinderen is een vorm van kanker in het bloedvormende systeem 
van het lichaam. De ziekte wordt veroorzaakt door een complex samenspel van 
genetische factoren en omgevingsinvloeden (zowel natuurlijke als door de mens 
geproduceerde). In België, Nederland en andere landen in Noordwest Europa 
worden elk jaar 5 op de 100.000 kinderen getroffen door deze ernstige 
aandoening, die een zware behandeling vergt. Het gemiddelde aantal nieuwe 
gevallen per jaar lag recent rond de 80 in België, en rond de 140 in Nederland.
Het grootste deel van de jonge patiëntjes lijdt aan acute lymfatische leukemie 
(ALL). Een kleiner percentage heeft acute myeloïde leukemie (AML). Dankzij 
de verbeteringen in behandeling en zorg die de afgelopen decennia in West-
Europese landen zijn gerealiseerd, overleeft zo’n 85% van de kinderen met ALL 
de eerste vijf jaar na de diagnose, en circa 60% van de kinderen met AML.
In het laatste decennium van de 20e eeuw heeft de incidentie van 
kinderleukemie een stijging laten zien. De vraag kwam daarbij op of dit kon 
samenhangen met een verhoogde blootstelling aan schadelijke omgevings-
factoren. Hoewel de trend nu gestopt lijkt te zijn of zelfs gekeerd, is er nog steeds 
alle reden om meer helderheid te krijgen over de mogelijke rol van omgevings-
factoren bij het ontstaan en de ontwikkeling van kinderleukemie. 
Dat is dan ook het doel van dit advies, dat is opgesteld door een gezamenlijke 
commissie van de Belgische Hoge Gezondheidsraad en de Nederlandse 
Gezondheidsraad. De commissie heeft zich bij haar evaluatie van de 
wetenschappelijke kennis en bij het formuleren van aanbevelingen laten leiden 
door het voorzorgprincipe.
Kennis over de invloed van omgevingsfactoren
Door het complexe samenspel tussen genetische afwijkingen en blootstelling aan 
natuurlijke en kunstmatige omgevingsfactoren is het lastig een helder beeld te 
krijgen van de rol die individuele factoren spelen. Op grond van de beschikbare 
kennis is de belangrijkste conclusie dan ook dat het merendeel van de gevallen 
van kinderleukemie niet verklaard kan worden, en dat slechts een klein deel te 
voorkomen zal zijn. Dit advies gaat over de mogelijkheden om binnen dat kleine 
deel een reductie te bewerkstelligen.
Alleen voor ioniserende straling is een oorzakelijk verband met 
kinderleukemie gevonden dat beschouwd kan worden als ‘aangetoond’. Samenvatting 15
Blootstelling aan dit type straling komt van nature voor, maar ontstaat ook door 
medische toepassingen, zoals röntgenfoto’s en in het bijzonder CT-scans.
Een verband tussen kinderleukemie en blootstelling aan benzeen is op basis 
van de huidige kennis beoordeeld als ‘waarschijnlijk’. Voor het roken door 
ouders en blootstelling aan bestrijdingsmiddelen is het bestaan van een verband 
beoordeeld als ‘mogelijk tot waarschijnlijk’. Verder zijn er twee beschermende 
invloeden die als ‘waarschijnlijk’ zijn gelabeld: het krijgen van borstvoeding en 
het bezoeken van een kinderdagverblijf of andere contacten tussen jonge 
kinderen.
Voor het merendeel van de fysische, chemische en andere omgevings-
invloeden die bestudeerd zijn kan het verband met kinderleukemie niet sterker 
worden aangeduid dan als ‘mogelijk’, ‘onzeker’ of ‘onbekend’.
Aanbevolen maatregelen
Op basis van deze bevindingen adviseert de commissie om naast de traditionele 
microbacteriële hygiëne ook ‘fysisch-chemische hygiëne’ toe te passen, om zo 
de blootstelling aan mogelijk schadelijke omgevingsinvloeden zoveel mogelijk 
te beperken. 
Vanwege het weinig robuuste wetenschappelijke bewijs en de beperkte 
mogelijkheden om de blootstelling aan natuurlijke invloeden te beperken, is er 
vooralsnog ook slechts een beperkte hoeveelheid maatregelen voorhanden om 
blootstellingen te reduceren of de mogelijkheden voor bescherming te benutten. 
Daarbij moet bovendien een evenwicht bewaard worden tussen voldoende 
voorzorg en te grote voorzichtigheid.
Een aantal uitgangspunten is echter duidelijk. De gemiddelde leeftijd waarop 
kinderen leukemie krijgen ligt rond de vijf jaar. Om effect te hebben moeten 
maatregelen daarom primair gericht zijn op peuters, zuigelingen, zwangere 
vrouwen en vrouwen (en hun partners) die zwanger willen worden. De 
commissie adviseert om vrouwen die zwanger willen worden te voorzien van 
informatie, zodat zij weten welke omgevings- en leefstijlfactoren schadelijk 
kunnen zijn. Verder ligt het in de lijn, nu nog zoveel onzeker is, om met de 
aanbevelingen aan te sluiten bij bestaand beleid en bij de richtlijnen die al zijn 
geformuleerd met het oog op het voorkomen van andere ziektes of risico’s. 
Binnen deze contouren kunnen de volgende aanbevelingen worden gegeven:
• Het is van belang om de blootstelling aan ioniserende straling voor medische 
doeleinden bij zwangere vrouwen en jonge kinderen te verminderen. Dit kan 
gerealiseerd worden wanneer medische professionals beter rekening houden 
met de risico’s bij de keuze voor diagnostische methoden.
• Hoewel een oorzakelijk verband met de huidige blootstelling aan echo’s die 
routinematig tijdens de zwangerschap worden gemaakt onwaarschijnlijk 16 Childhood leukaemia and environmental factors
wordt geacht, zouden echo’s niet aangeboden moeten worden zonder 
medische indicatie, om zo de blootstelling aan ultrageluid te beperken.
• Een belangrijke maatregel is ook om de blootstelling aan 
bestrijdingsmiddelen te beperken, in het bijzonder voor zwangere vrouwen 
op het werk en thuis, en voor vrouwen die zwanger willen worden. Beide 
groepen zouden niet met bestrijdingsmiddelen moeten werken, of extra 
beschermingsmaatregelen moeten nemen.
• Aangezien roken (zowel van tabak als marihuana) en alcoholgebruik door 
ouders kunnen leiden tot diverse negatieve gezondheidseffecten bij kinderen, 
zijn op dat punt al richtlijnen geformuleerd. Een oorzakelijk verband van 
deze leefstijlfactoren met kinderleukemie is weliswaar niet aangetoond, maar 
de mogelijkheid van zo’n verband kan een extra reden zijn om van roken en 
alcoholgebruik af te zien, in het bijzonder in de periode voorafgaand aan de 
conceptie en tijdens de zwangerschap.
• Het is ook aan te raden, gegeven de onzekerheid over een oorzakelijk 
verband met kinderleukemie, dat zwangere vrouwen geen vlees eten dat is 
behandeld met nitriet, zoals ham, spek en worst. 
• Tot slot bevestigen de bevindingen dat borstvoeding mogelijk beschermt 
tegen kinderleukemie het belang van de bestaande aanbeveling om, wanneer 
dat kan, borstvoeding te geven tot de leeftijd van zes maanden.
Noodzaak van meer kennis
Hoewel de wetenschappelijke kennis zich zeker ontwikkelt, is over het verband 
tussen omgevingsinvloeden en kinderleukemie vooralsnog veel onduidelijk of 
betrekkelijk onzeker. De bevindingen in dit advies laten duidelijk zien waar 
verder onderzoek nodig is. 
Aangezien het aantal patiënten per land vaak te klein is om een verband 
tussen oorzaken en gevolgen aan te kunnen tonen, is internationaal onderzoek 
naar de incidentie van kinderleukemie en de relatie met omgevingsfactoren 
noodzakelijk. Tegelijk is specifiek onderzoek nodig, met name naar de nadelige 
effecten van het gebruik van bestrijdingsmiddelen en naar eventuele effecten van 
frequent gebruik van echo’s. Ook moet onderzoek gedaan worden naar de 
stapeling van risico’s als gevolg van meervoudige blootstelling; dat is een 
onderwerp dat tot dusverre nog nauwelijks aandacht heeft gekregen. Samenvatting 17
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Résumé
La leucémie infantile est une forme de cancer affectant le système 
hématopoïétique du corps humain. La maladie est provoquée par l’interaction 
complexe de facteurs génétiques, naturels et environnementaux produits par 
l’homme. En Belgique, aux Pays-Bas et dans d’autres pays d’Europe du nord-
ouest, 5 enfants sur 100.000 sont touchés chaque année par cette maladie grave, 
nécessitant un traitement lourd. Au cours des dernières années, le nombre moyen 
de nouveaux cas par an se situait autour de 80 en Belgique et de 140 aux Pays-
Bas.
La plupart des jeunes patients souffrent de leucémie aiguë lymphoblastique 
(LAL). Un pourcentage plus faible est atteint de leucémie aiguë myéloblastique 
(LAM). Grâce aux améliorations apportées au traitement et aux soins dans les 
pays d’Europe de l’Ouest au cours des dernières décennies, quelque 85% des 
enfants atteints de LAL survivent durant cinq ans après le diagnostic et environ 
60% des enfants atteints de LAM.
Le nombre de cas de leucémie infantile a présenté une augmentation durant 
la dernière décennie du 20ème siècle. La question qui se pose dès lors est de 
savoir si cette augmentation peut être corrélée à une exposition accrue à des 
facteurs de risque. Bien que cette tendance semble maintenant stoppée voire 
inversée, il n’en reste pas moins nécessaire d’obtenir plus de précision au sujet 
du rôle des facteurs environnementaux dans l’apparition et le développement de 
la leucémie infantile. 
Le présent avis, élaboré conjointement par le Conseil Supérieur de la Santé 
de Belgique et le Gezondheidsraad des Pays-Bas, a donc pour objectif d’y 
parvenir. Cette commission mixte s’est basée sur le principe de précaution pour 
évaluer les connaissances scientifiques et formuler des recommandations. 
Preuves concernant l’impact des facteurs environnementaux
En raison de l’interaction complexe entre anomalies génétiques et expositions à 
des facteurs environnementaux naturels et artificiels, il n’est pas facile de 
déterminer clairement le rôle joué par les différents facteurs. Sur base des 
connaissances disponibles, les principales conclusions sont donc que la plupart 
des cas de leucémie infantile ne peuvent s’expliquer et que seule une petite partie 
des cas pourra faire l’objet d’une prévention. Le présent avis traite des 
possibilités de parvenir à une réduction au sein de cette petite fraction.Résumé 19
Seules les radiations ionisantes présentent un lien causal considéré comme 
‘démontré’ avec la leucémie infantile. L’exposition à ce type de rayonnements 
est présente dans la nature mais est également générée par des applications 
médicales telles que les radiographies et en particulier les CT-scans.
En l’état actuel des connaissances, un lien entre la leucémie infantile et 
l’exposition au benzène est considéré comme ‘vraisemblable’. En ce qui 
concerne le tabagisme parental et l’exposition aux pesticides, l’existence d’un 
lien est jugée ‘possible à vraisemblable’. En outre, deux influences protectrices 
sont qualifiées de ‘vraisemblables’: l’allaitement maternel et la fréquentation 
d’une crèche ou tout autre contact entre jeunes enfants.
Pour la majorité des facteurs environnementaux physiques, chimiques et 
autres étudiés jusqu’à présent, la vraisemblance du lien causal avec l’apparition 
d’une leucémie infantile ne peut être qualifiée que de ‘potentielle’, ‘incertaine’ 
ou ‘inconnue’.
Mesures recommandées
Au vu des constatations reprises dans le présent rapport, la commission préconise 
d’appliquer, outre la traditionnelle hygiène antimicrobienne, également 
‘l’hygiène physico-chimique’ afin de limiter autant que possible les expositions 
environnementales à des agents potentiellement nocifs. 
Vu le manque de consistance de la plupart des connaissances scientifiques et 
le peu d’opportunités de réduire le rôle des expositions naturelles, les mesures 
disponibles en vue de limiter les expositions potentiellement nocives ou de 
mettre à profit les possibilités de protection sont encore peu nombreuses. Dans ce 
contexte, il est nécessaire de trouver un équilibre entre précautions suffisantes et 
prudence excessive.
Certains principes sont pourtant clairs. L’âge médian auquel apparaît la 
leucémie infantile est d’environ cinq ans. Pour être efficaces, les mesures 
devront dès lors viser principalement les enfants d’âge préscolaire, les 
nourrissons, les femmes enceintes et les femmes souhaitant être enceintes (et 
leurs partenaires). La commission recommande d’informer les femmes en âge de 
procréer afin qu’elles prennent conscience du risque que représentent certains 
facteurs environnementaux et comportementaux avant d’envisager toute 
conception. En outre, au vu des incertitudes qui subsistent, il est logique que les 
suggestions émises soient conformes à la politique et aux directives déjà 
implémentées dans le cadre de la protection contre d’autres maladies ou risques. 
Dans les limites fixées par ces paramètres, les recommandations suivantes 
peuvent être formulées:
• Priorité doit être accordée à la réduction de l’exposition aux radiations 
ionisantes à des fins médicales chez les femmes enceintes et les jeunes 
enfants. Une meilleure prise en compte des risques par les professionnels lors 
du choix des méthodes diagnostiques permettrait d’y parvenir.20 Childhood leukaemia and environmental factors
• Bien qu’un lien causal avec les doses d’exposition utilisées actuellement 
dans le cadre des échographies réalisées en routine durant la grossesse soit 
considéré comme invraisemblable, ces échographies ne devraient pas être 
proposées sans indication médicale afin de limiter l’exposition.
• Une importante mesure consiste à réduire l’exposition aux pesticides, en 
particulier pour les femmes enceintes susceptibles d’être exposées au travail 
ou à domicile et pour les femmes souhaitant procréer. Elles devraient 
s’abstenir d’utiliser des pesticides dans le cadre du travail ou appliquer des 
mesures supplémentaires de protection.
• Il est notoire que la consommation de tabac (et de marijuana) et d’alcool par 
les parents est susceptible d’engendrer divers effets néfastes sur la santé des 
enfants. Des directives existent donc déjà concernant ces facteurs 
comportementaux. Bien que le lien causal avec la leucémie infantile n’ait pas 
été établi, la possibilité d’un tel lien peut donner une crédibilité 
supplémentaire au présent avis qui encourage à s’abstenir de fumer et de 
boire, en particulier si l’on souhaite procréer et durant la grossesse.
• Il est également conseillé, vu l’incertitude concernant le lien causal avec la 
leucémie infantile, que les femmes enceintes évitent de consommer de la 
viande traitée au nitrite comme le jambon, le bacon et les saucisses.
• Enfin, la recommandation actuelle d’allaiter dans la mesure du possible 
jusqu’à l’âge de six mois se trouve renforcée par le fait que l’allaitement a 
probablement aussi un effet protecteur contre la leucémie infantile.
Nécessité de connaissances supplémentaires
Bien que les connaissances se soient développées, il subsiste beaucoup 
d’incertitude ou d’incompréhension quant aux causes environnementales de la 
leucémie infantile. Les conclusions du présent rapport montrent clairement les 
domaines dans lesquels des études complémentaires sont les plus nécessaires.
Le nombre de patients par pays étant souvent trop peu élevé pour établir un 
lien de cause à effet, des études internationales sur l’incidence de la leucémie 
infantile et son lien avec des facteurs environnementaux sont requises. Dans le 
même temps, des études doivent être menées concernant des facteurs 
spécifiques, en particulier les effets néfastes de l’utilisation de pesticides et tout 
effet potentiel de l’utilisation fréquente des ultrasons. Des recherches doivent en 
outre être réalisées quant aux risques cumulatifs dus à des expositions 
simultanées, un sujet qui, jusqu’à présent, n’a guère été étudié. Résumé 21
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1 Introduction
1.1 Why this report?
What is the role of environmental factors in the onset of childhood leukaemia? 
This question has been the subject of a multitude of scientific studies. It has also 
been frequently discussed in the media and among concerned individuals. Given 
the increasing body of publications of different origin, it can be hard to keep 
track of the scientifically established knowledge about this important issue, and 
to consider measures based on sufficient evidence. 
It is the aim of this advisory report to address the question of environmental 
influences on the induction and development of childhood leukaemia, using the 
best available and most recent scientific insights. To do so, the Belgian Superior 
Health Council (SHC) and the Health Council of the Netherlands (HCN) have 
engaged in a joint advisory process, initiated by paediatric oncologists in 
Belgium, operating within the framework of the European Science Advisory 
Network for Health (EuSANH).
Burden of disease and impact on society
Leukaemias are cancers of the haematopoietic (blood forming) system. Although 
rare, they are the most common malignancies in early childhood. During the last 
two decades of the past century, the average annual incidence* of all childhood 
leukaemias in Europe was 4.4 per 100,000 per year.1
Leukaemia occurs when immature white blood cells, produced in the bone 
marrow, keep multiplying. Different types of leukaemia originate from different 
cell types: lymphoid or myeloid cells. Therefore, leukaemia can be classified as 
lymphoid or myeloid, and as either acute or chronic. The majority 
(approximately 80%) of childhood leukaemias are acute lymphoblastic or 
lymphoid leukaemias (ALL). The remainder consists almost exclusively of acute 
myeloid leukaemia (AML). Chronic forms of childhood leukaemia are rare.2 
The median age of childhood leukaemia patients is low overall, but shows a 
difference where the two types are concerned, ALL patients being younger (4 
years, 9 months) than patients with AML (6 years, 1 month).3 As the latency 
period can be several years, possible causes of childhood leukaemia may be 
* Incidence: the frequency of new cases within a certain period.Introduction 23
found very early in childhood, in pregnancy, or even before conception. The 
same applies to possibly protective environmental influences. 
Although improvements in treatment and care have led to a remarkable 
increase in survival rates in recent years, childhood leukaemias require 
burdensome and complication-prone treatments and remain lethal in a significant 
proportion of cases. In Western European countries the 5-year survival rate 
between 1988 and 1997 has been approximately 85% for ALL and less than 60% 
for AML.4 Because of the young age of children with leukaemia, the mean 
number of disability related life years or years lost is relatively high compared to 
other cancers. 
Trends in incidence and supposed role of the environment
Between 1978 and 1997 the age-standardised incidence rates for leukaemia in 
about twenty European countries have shown a slow but continuous rise from 4.0 
to 4.5 per 100,000 children (age 0-14).1,4,5 This increase can only partly be 
explained by changes in diagnostic methods and registration artefacts.5 The 
patterns and magnitude of the increase therefore suggest that changes in lifestyle 
and in exposure to a variety of agents have contributed to the observed increase.5
A vast body of scientific literature on environmental factors that may be 
associated with the induction and development of childhood leukaemia is 
available, ranging from ionising radiation, electromagnetic fields and chemicals 
such as pesticides to infectious agents and lifestyle factors. In recent years 
several publications have discussed the incidence of childhood leukaemia around 
nuclear facilities in Germany and the observed associations with living near 
overhead power lines or with pesticide exposures.6-9
The specific dynamics of exposure in children can be expected to differ from 
that in adults. In addition to exposure during childhood, exposure of the mother 
during pregnancy and exposure of the parents before conception can also play a 
role. Furthermore, children are in general considered to be more sensitive to 
external influences, as a result of their developing physiology and behaviour. 
This sensitivity is especially high during the first weeks after conception, when 
parents might not even be aware of the pregnancy. 
Gene-environment interactions
Exposure to environmental factors is, however, not the only cause. Gene 
mutations have been shown to play a central role in the aetiology of childhood 
leukaemia. Especially ALL, the most common type of cancer in children, is a 
heterogeneous disease in which different types of genetic abnormalities result in 
the development of multiple genetic subtypes (see 4.1). Genetic and 
environmental factors, and different types of environmental factors, may also be 
expected to interact. Different types of leukaemia may respond differently to 24 Childhood leukaemia and environmental factors
environmental factors. Moreover, some environmental influences may offer a 
measure of protection against childhood leukaemia. In exploring the role of 
environmental influences, these also need to be taken into account.
1.2 The Committee, its working procedures and objectives
Committee
The Chair of the SHC and the President of the HCN have established a 
multidisciplinary Committee to prepare an advisory report on the association 
between environmental factors and the incidence of childhood leukaemia. Its 
membership is listed in Annex A.
Working procedures
The Committee met eight times. During the review process several external 
experts were consulted (Annex B). Most of them were members of the HCN 
Standing Committees on Radiation and Health, on Health and the Environment, 
on Medicine and on Public Health, and members of the Reflection Groups 
Ionising Radiation and Non-Ionising Radiation and Chemical Agents of the 
SHC. A draft was also reviewed by members of EuSANH. The written 
comments have been discussed in a joint meeting with several reviewers. Finally 
the report has been validated by the Boards of the SHC and of the HCN. 
Objectives
Given the rise in incidence and the possible association with environmental 
factors, the Committee’s aim is to review the evidence, consider possible causal 
relationships and draw up recommendations for measures that could reduce the 
incidence of childhood leukaemia. To reach this aim, the Committee formulated 
the following objectives:
1 Collect epidemiological data from Belgium and the Netherlands on 
childhood leukaemia and discuss this in a European context.
2 Consider the evidence on genetic risk factors of childhood leukaemia.
3 Review the evidence on environmental factors regarding childhood 
leukaemia, discuss the relevance of indicators of environmental exposures 
and consider possible causal relationships with childhood leukaemia.
4 Propose measures to reduce the impact of environmental risk factors on 
childhood leukaemia, propose risk communication strategies, and advise on 
further research.
In dealing with the question of environmental factors, the Committee discusses 
physical, chemical and biological influences, excluding medication. Factors that Introduction 25
may be relevant as potential confounders* and effect modifiers**, such as genetic 
susceptibility, lifestyle factors and socio-economic status, are also taken into 
account. A review of diagnosis, treatment and survival rates of childhood 
leukaemia, however, is outside the scope of this advisory report.
1.3 Content of this report
In Chapter 2 the review methods are described. Chapter 3 is concerned with the 
first objective of the Committee: collecting and discussing the incidence data on 
childhood leukaemia in Belgium and the Netherlands within a European context. 
Chapter 4 deals with the relevance of genetic susceptibility. In Chapter 5, 6 and 7 
the Committee reviews the evidence for causal relationships between the 
occurrence of childhood leukaemia and physical, chemical and other 
environmental exposures, thus addressing the third objective. Chapter 8 presents 
the overall conclusions of the Committee and the recommendations for risk 
management, risk communication and options for further research – the last 
objective of this advisory report.
* Confounder: known risk factor for a disease associated with the exposure under study, which is not 
functioning as an intermediary factor in the causal relationship between exposure and effect (e.g. life 
style factors of socioeconomic status).10 
** Effect modifier: factor that modifies the measure of effect of a causal factor under study (e.g. genetic 
susceptibility or age of exposure).1126 Childhood leukaemia and environmental factors
2 Perspectives and review methods
2.1 A precautionary perspective
As will become clear from this report, knowledge about the impact of 
environmental and lifestyle factors on the occurrence of childhood leukaemia is, 
with a few exceptions, highly uncertain. In situations such as these, which are 
also characterised by complexity and ambiguity*, a precautionary perspective is 
recommended to guide the risk assessment and subsequent risk management.12
Thus, the available scientific knowledge should be weighed with precaution in 
mind, sources of knowledge outside the area of science could be taken into 
account, and policy measures could be evaluated accordingly.
Benefits and costs always have to be balanced, but this is especially 
important when gaps in knowledge exist and possibly detrimental influences can 
be serious. Taking a precautionary perspective, measures could then be 
recommended of which the effect on the occurrence of childhood leukaemia is 
uncertain or thought to be limited, but that at least also will have other benefits.
2.2 Sources of scientific evidence
Scientific evidence for possible relationships between exposure to an 
environmental factor and childhood leukaemia is available from two sources: 
epidemiological and experimental data. 
On the one hand, relevant evidence can be obtained from observational 
studies: epidemiological research in which the association between exposure to 
an environmental factor and the disease is explored. The three most important 
types of epidemiological studies are cohort studies, case-control studies and 
ecological studies**. 
Epidemiological studies generally produce equivocal results, and for that 
reason the results are often insufficient to conclusively establish causal 
relationships.
* Ambiguity relates to different value judgements and conflicting interpretations of the scientific 
knowledge and controversies about the factors that may cause the risks.
** In a cohort study a large group of initially healthy subjects is followed for long periods of time, 
varying from years to decades. Exposure to the factor of interest and the occurrence of disease is 
monitored, and in due time associations can be determined. This is usually a prospective type of 
study, which allows adequate exposure assessment. In a case-control study a group of patients with 
the disease of interest is selected, and for each case one or more control subjects is sought who do not 
suffer from the disease. A comparison between case-control pairs is then made regarding exposurePerspectives and review methods 27
On the other hand, experimental data can be obtained in the laboratory by 
exposing human or animal cells (in vitro studies) or experimental animals (in 
vivo studies) to environmental factors. In some cases effects can be studied by 
exposing volunteers (human studies). In this way, knowledge can be gathered 
about mechanisms that might explain the associations observed in 
epidemiological studies or that indicate a possible role for a specific risk factor, 
even if relevant associations have not been observed or investigated.
In this report, the Committee uses four approaches to obtaining evidence for 
possible environmental influences on the incidence of childhood leukaemia.
Systematic reviews on childhood ALL and AML
The first line of enquiry has been to commission The Cochrane Childhood 
Cancer Group (CCG) in Amsterdam to prepare a systematic review of the 
available epidemiological evidence on the aetiology of childhood leukaemia. The 
literature retrieval followed a strict protocol with specific inclusion criteria, and 
items for study quality assessment were a priori defined in the study protocol. 
Only publications evaluating ‘environmental factors’ were included that 
pertained to childhood leukaemia (i.e. that included subjects younger than 18 
years at the time of diagnosis) and that presented data on ALL and/or AML 
separately. Because of the very large number of publications retrieved by the 
initial search, inclusion was limited to systematic reviews and meta-analyses 
with a systematic literature search published between 1990 and March 2010. 
The year 1990 was chosen as a starting point since diagnostic methods to 
reliably differentiate between ALL and AML were not available before the 
1980s, and pooling the data is not appropriate, given the different aetiology of 
the two types of leukaemia. The first eligible publications could therefore be 
expected to have appeared from 1990 onwards. One review per aetiological 
factor was selected: either the most recent one or the one with the largest search 
period. 
The CCG has presented its findings in an ‘Evidence Summary’, which is 
published in conjunction with this report.225 Summary tables derived from the 
CCG Evidence Summary are included in this report in Annex C. Conclusions 
from a systematic review of systematic reviews, such as the CCG Evidence 
Summary, are always based on an analysis of the primary data by the authors of 
to the factor of interest. This allows for conclusions on whether exposure is higher in the cases, which 
might be an indication of causality. One of the main problems with this type of study is that exposure 
has to be determined retrospectively, and often on the basis of recollection by the subjects. In an 
ecological study the occurrence of disease at the population level is investigated in relation to 
exposure to the factor of interest. A limitation of this type of study is the usually poor level of insight 
into trends and patterns of exposure at the population level, and the retrospective assessment of 
exposure. Another main problem is that information on confounding factors is generally missing or is 
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the original systematic reviews. However, if information on the primary data is 
not available, specific aspects, such as the quality of the included studies, cannot 
be discussed. Because of this limitation, and the wider scope of its objectives, the 
Committee also studied other evidence. 
Systematic reviews on childhood leukaemia in general
Given the focus on systematic reviews and the required separate analysis of ALL 
and AML, the CCG Evidence Summary did not include several possibly 
important aetiological factors. From a clinical point of view this selection was 
warranted, but the Committee decided that additional information, specifically 
relevant for identifying the environmental factors associated with the aetiology 
of childhood leukaemia, should be weighed as well. It therefore systematically 
evaluated the data on childhood leukaemia in general, which were identified in 
the original CCG search for systematic reviews. 
Ten systematic reviews were thus identified in the CCG search, in each of 
which 50% or more of the studies had been eliminated, as they only addressed 
childhood leukaemia in general. The results of the evaluation of these studies are 
presented in an ‘Evidence Summary on Childhood Leukaemia in General’, 
which is published alongside this report.213 Summary tables derived from this 
Evidence Summary are included in Annex D.
Other epidemiological evidence
The CCG search focussed on systematic reviews that were published between 
1990 and March 2010. As a consequence, systematic reviews published before 
1990 were not included, and neither were narrative reviews. Moreover, 
dependent on their objectives, the systematic reviews did not review all earlier 
studies. Because important information from relevant studies could have been 
missed, the Committee identified key publications or reports from authoritative 
national or international expert panels, including results published before 1990 
and reviews published since March 2010.
Experimental evidence
In order to assess causality, information on the mechanisms of leukaemogenesis 
also had to be taken into account. This means that in addition to epidemiological 
data, results from experimental studies needed to be considered.
The IARC*, an agency of the WHO, has evaluated several relevant risk 
factors and classified them according to their carcinogenicity. The Committee 
has taken into account the IARC Monographs in which these results are 
* IARC: the International Agency for Research on Cancer of the World Health Organization (WHO).Perspectives and review methods 29
presented. For some factors, such as ionising radiation, Committee members 
contributed additional experimental information.
In weighing the information, the Committee has considered that not all 
agents that have been shown to cause cancer in experimental animals can also be 
expected to cause cancer in humans, although the animal studies may strengthen 
the biological plausibility of an association.13 Similarly, if an agent has been 
found to be carcinogenic in humans, this does not necessarily mean that it may 
cause (childhood) leukaemia.
2.3 Classifying evidence and possible causality
In evaluating the evidence for an aetiological role of environmental factors in the 
initiation or development of childhood leukaemia, the Committee considered two 
questions:
• What is the evidence for an association between the exposure to certain 
environmental factors and the incidence of childhood leukaemia?
• What is known about possible mechanisms that would explain an observed or 
hypothesised association between the exposure to certain environmental 
factors and the incidence of childhood leukaemia?
In answering the first question, the findings from epidemiological research play a 
central role. In answering the second question, evidence from experimental 
research is of primary importance. 
To evaluate the strength of evidence for a causal relationship between an 
environmental factor and childhood leukaemia, the Committee has taken into 
account the well-established considerations put forward by Bradford Hill to 
interpret epidemiological studies: temporality, biological gradient (or exposure-
response), consistency, strength, specificity, plausibility, coherence, experiment, 
analogy (see also Annex E).14,15 
Evidence
The Committee has classified the epidemiological evidence for an association 
between the exposure to an environmental factor and the incidence of childhood 
leukaemia, using a modified version of the classifications by IARC and Wigle 
(see Annex F). The conclusions are presented on a three point-scale: 16,17
• Sufficient (based on results from high-quality systematic reviews or other 
overwhelming evidence, e.g. high-quality large scale observational studies).
• Limited (based on results from low-quality systematic reviews or high-
quality observational studies).
• Inadequate (based on results from low-quality observational studies or expert 
opinions).30 Childhood leukaemia and environmental factors
Accordingly, the biological plausibility has been classified as high, moderate or 
low, as far as could be assessed from the available literature.
Possible causality
The Committee has classified its conclusions on a causal contribution of 






These qualifications are based on the levels of epidemiological evidence and 
biological plausibility, as presented in the following table for the likelihood of 
causality:
In some classifications a fourth category of scientific evidence is added, to 
indicate whether there is sufficient evidence for the absence of (i.e. evidence 
against) an association or relation with a specific risk factor. In those situations a 
causal relation is classified as ‘unlikely’. However, where environmental risk 
factors of childhood leukaemia are concerned this appeared seldom to be the 
case.
2.4 Presenting quantitative information on risks
When available, the Committee has presented quantitative information on the 
incidence of childhood leukaemia resulting from exposure to environmental 
factors in the form of the estimated fraction of childhood leukaemia cases that 
can be attributed to a given risk factor. This ‘population attributable fraction’ or 
PAF (sometimes called ‘population attributable risk’ or PAR) is expressed as a 
percentage.
Two types of information are needed to estimate the PAF:18
• The relative risk (RR): an estimate of the effect of exposure on the incidence 
of the disease.
• The prevalence (P) of exposure in the population.
Levels of scientific evidence Epidemiological evidence for an association
Sufficient Limited Inadequate
Biological 
plausibility for a 
causal relation
High Established Likely Possible
Moderate Likely Possible Uncertain
Low Possible Uncertain UnknownPerspectives and review methods 31
The formula to calculate the PAF is:
PAF=[P*(RR-1)] / [1+P(RR-1)] * 100.
However, in most cases the information on exposure distribution required to 
perform this estimation is not available. The Committee has therefore attempted 
to provide expert calculations whenever it was possible to do so, in some cases 
using the exposure distribution of control groups as an estimate for the 
population as a whole. When applicable, this is stated explicitly. 
2.5 Presenting recommendations
The Committee recommends measures that may contribute to the reduction of 
childhood leukaemia in the framework of precaution (see 2.1). The problem is 
complex and risk is created by a sequence of multifactorial elements. Causal 
evidence and plausibility range from ‘unknown’ to ‘established’, depending on 
the nature of contributing factors, while value judgements can differ.
How has the Committee arrived at these recommendations?
First, recommendations can be derived from available epidemiological evidence. 
Where this approach is applicable, the Committee has followed Wigle:17
• Where relationships between adverse health effects in children and 
environmental exposures are supported by sufficient evidence of causal 
relationships, there is a need for (a) policies and programs to minimise 
population exposures and (b) population-based biomonitoring to track 
exposure levels, through ongoing or periodic surveys with measurements of 
contaminant levels in blood, urine and other samples. 
• For relationships supported by limited evidence, there is a need for targeted 
research and policy options ranging from ongoing evaluation of evidence to 
proactive actions. 
• There is a great need for population-based, multidisciplinary and 
collaborative research on the many relationships supported by inadequate 
evidence, as these represent major knowledge gaps. 
Which types of measures are appropriate depends on a large number of factors, 
including:
• The nature of the risk.
• The benefits of the activities associated with the risk.
• The availability of feasible measures or alternatives.
• The disadvantages (other risks and costs) of measures.32 Childhood leukaemia and environmental factors
Finally, recommendations can be based on the quantitative contribution of a risk 
factor to the occurrence of a disease, expressed as the population attributable 
fraction (PAF) and defined as the proportional reduction that would occur if 
exposure were to be reduced to zero. Where formulating policies is concerned, 
this is the most important estimate.19 Mostly, however, it is not possible to 
determine the PAF, due to a lack of data on the distribution of exposure in the 
target population.Perspectives and review methods 33
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3 Incidence of childhood leukaemia
In this chapter, the Committee presents epidemiological data on childhood 
leukaemia from Belgium and the Netherlands. In Belgium, childhood leukaemia 
is defined as acute leukaemia diagnosed before the age of fifteen, in the 
Netherlands before the age of eighteen. To allow a comparison, data from the 
Netherlands are also provided for the 0-14 years age group. Subsequently, the 
results are discussed in a European context. The chapter concludes with a 
paragraph on reported clusters of incidence.
3.1 Incidence in Belgium
In Belgium, the Belgian Cancer Registry (BCR) is responsible for data 
collecting. Data are available for all regions (Flanders, Wallonia and Brussels) 
from 2004 onwards.20 For Flanders, population-based data are available from 
1999. In Table 1 the childhood leukaemia incidence rates (WSR*) in Belgium are 
presented.
* WSR (World Standardised incidence Rate): weighted average of the individual age-specific rates 
using the World Standard Population for standardisation, expressed as the number of new cases per 
100,000 person-years.
Table 1. Leukaemia in children (0-14 years) in Belgium (2004-2008): absolute numbers over the  
5-year period and standardised incidence rates (WSR) by diagnosis.
ICCCa category
a  International Classification of Childhood Cancer.21
Absolute numbers  
(total male and  
female)
Incidence rate (number/ 
100,000 person-years; 
total male and female)
Percentage of total
Ia  Acute lymphoid
leukaemias
333 3.95 79
Ib Acute myeloid leukaemias 61 0.71 15
Ic  Chronic myelopro-
liferative diseases
6 0.06   <1
Id  Myelodysplastic
syndromes and other 
myeloproliferative 
diseases
18 0.21   4
Ie  Unspecified and 
other leukaemias
2 0.02   <1
Total 420 4.94 100Incidence of childhood leukaemia 35
Figure 1. Age-specific incidence rates of leukaemia in children (0-14 years) in Belgium (2004-2008).
For the period 2004-2008, 23% of all childhood cancers were leukaemias. The 
average number of new cases per year was 67 for ALL and 12 for AML. The 
standardised incidence rate (WSR) was 3.95 per 100,000 person-years for ALL 
and 0.71 for AML. In Figure 1 the childhood leukaemia age-specific incidence 
rates in Belgium are presented.
As complete data collection in all regions only started in 2004 and only small 
numbers of cases are involved, the data have a large variability. In Flanders, 
incidence rates of childhood leukaemia are available from 1999 onwards. The 
yearly incidence (WSR) for ALL and AML in Flanders between 1999 and 2008 
is presented in Figure 2.
For the period 1999-2008 the estimated annual percentage of change (EAPC) 
showed a non-significant decrease: -2.57% for ALL (p=0.23) and -5.01% for 
AML (p= 0.44).
3.2 Incidence in the Netherlands
In the Netherlands, the Dutch Childhood Oncology Group (DCOG) is 
responsible for collecting data on childhood cancers diagnosed up to 18 years of 
age. Data are available from all seven childhood oncology centres, starting in 
1972.20,22 Since 1984, data are available per type of leukaemia (ALL/AML). 36 Childhood leukaemia and environmental factors
Figure 2. Yearly incidence (WSR) of ALL and AML in children (0-14 years) in Flanders  
(1999-2008).
In Table 2 the childhood leukaemia incidence (WSR) in the Netherlands is 
presented.
For 2004-2008 the average number of new cases per year was 108 for ALL and 
23 for AML. The standardised incidence rate (WSR) per 100,000 person-years 
was 3.77 for ALL and 0.81 for AML.
Table 2. Leukaemia in children (0-14 years) in the Netherlands (2004-2008): absolute numbers over 
the 5-year period and standardised incidence rates (WSR) by diagnosis.
ICCCa category
a International Classification of Childhood Cancer.21
Absolute numbers
(total male and 
female)
Incidence rate 





Ia  Acute lymphoid
leukaemias
537 3.77 75
Ib Acute myeloid leukaemias 115 0.81 16
Ic  Chronic myelopro-
liferative diseases
  12 0.07    2
Id  Myelodysplastic
syndromes and other  
myeloproliferative diseases
  47 0.35    7
Ie  Unspecified and 
other leukaemias
    4 0.04     <1
Total 715 5.04 100Incidence of childhood leukaemia 37
Figure 3. Age-specific incidence rates of leukaemia in children (0-14 years) in the Netherlands  
(2004-2008).
In the case of ALL, 45% of the children is diagnosed at 1-4 years of age, 33% at 
5-9 years of age, 15% at 10-14 years of age (Figure 3).23 Another 7% are 
diagnosed at 15-17 years of age. The latter group is sampled ‘registry based’ 
instead of ‘population based’, and is therefore not presented here. ‘Registry 
based’ means that children are only included in the DCOG registry if they are 
treated in a paediatric oncology centre. Children aged 15-17 are sometimes 
referred to a haematologist for adults.
In Figure 4 the incidence (WSR) of ALL and AML in the Netherlands between 
1988 and 2010 is presented.
Over the whole period, 1988-2010, the estimated annual percentage of change 
(EAPC) has not been statistically significant: 0.57% for ALL (p=0.10) and -
0.45% for AML (p= 0.44). However, broken down per decade, the incidence of 
ALL shows a statistically significant increase of 2.5% (p=0.003) from 1990 to 
2000, and a non-significant decrease of -1.9% (p=0.07) from 2000 to 2010. The 
incidence of AML shows a non-significant decrease of -1.9% (p=0.17) from 
1990 to 2000, and a non-significant decrease of -1.5% (p=0.52) from 2000 to 
2010. According to the DCOG registry, the increase of ALL in the nineties 
cannot be explained by registration artefacts, since the registry has already 
started in the seventies and has not been changed since the eighties.23 38 Childhood leukaemia and environmental factors
Figure 4. Yearly incidence (WSR) of ALL and AML in children (0-14 years) in the Netherlands 
(1988-2010).
3.3 Incidence in Europe
The standardised incidence rates (WSR) per 100,000 person-years for all 
childhood leukaemias combined over the period 2004-2008 are comparable for 
Belgium and the Netherlands (see Table 3). They are also approximately similar 
to the incidence rates in France over the period 2000-2004, to those in Sweden 
over the period 1990-1998 and to those in Europe as a whole over the period 
1993-1997. However, as this comparison is based on incidence rates over 
different time periods, caution in drawing conclusions is required.
The incidence of childhood leukaemia in general (‘all types’) is statistically 
higher in Northern Europe (Scandinavia: 4.8 per 100,000 person-years, aged  
0-14) and statistically lower in eastern Europe (3.9 per 100,000 person-years, 
aged 0-14) than the incidence determined for Europe as a whole.1 












ALL 3.95 3.77 3.42 4.01 3.72
AML 0.71 0.81 0.72 0.49 0.65
All types 4.94 5.04 4.59 5.10 4.45Incidence of childhood leukaemia 39
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During the last two decades of the past century the incidence of childhood
leukaemia in Europe has shown an increase. This particularly applies to ALL,
where a rise of 0.8% per year was seen in children (age 0-14 years: p<0.0001),
and a rise of 1.9% per year occurred among adolescents (age 15-19 years:
p=0.008).4 This increase can only partly be explained by changes in diagnostic
methods and registration artefacts.5 
It is currently unclear whether the increase in leukaemia incidence has
continued in recent years. Data from the Netherlands and Belgium suggest no
further increase since the year 2000. An update on the time trend of leukaemia
incidence in Europe by the ACCIS* project, which is expected to be available by
the end of 2012, may be able to confirm this.
3.4 Reported clusters and statistical clustering of incidence
When dealing with the incidence of childhood leukaemia, one other topic needs
to be addressed. There are many reports about ‘clusters’: unusually high numbers
of cases in a given area, period or population.26 Statistically significant excess
occurrences of leukaemia have been reported in a large variety of situations, for
example: in a horticultural community in the Netherlands,27 near nuclear power
plants in Germany and the UK,7,28 in areas around military encampments in
England and Wales,29 in villages with wartime evacuation refugees in England
and Wales,30 in rural areas with a high proportion of oil industrial workers in
Scotland,31 near large rural construction sites (coal fired or hydropower stations
and refineries) in Great Britain,32 in the neighbourhood of a navy base in the
US,33 and near a coke by-products plant of a steel factory in Australia.34
Some of these clusters will have occurred by chance: children with
leukaemia who happen to live in close proximity. In other cases, however, a
statistical variation should be considered very unlikely, since the difference
between the number of observed and expected cases is too large to be attributed
to chance alone. Different mechanisms have been proposed to explain these
occurrences. 
The British Committee on Medical Aspects of Radiation in the Environment
(COMARE) has studied the question as to whether or not childhood cancers have
a ‘natural’ tendency to aggregate or ‘cluster’ closer in space or time than one
would expect by chance alone.35 It appeared that the incidence of childhood
leukaemia in Great Britain (1969-1993) occurred in a non-random pattern,
varying more than would be expected if it were due to chance variations. These
results are consistent with the hypothesis that a non-random distribution of
leukaemia cases could be associated with the geographical distribution of
environmental risk factors. In the British study, however, it could not be
established what these factors were.
* ACCIS: Automated Childhood Cancer Information System.
The modest evidence for time-space clustering is compatible with the 
‘population-mixing’ hypothesis of Kinlen and the ‘delayed-infection’ hypothesis 
of Greaves.36 Both hypotheses posit that childhood leukaemia is a rare response 
to one or more common infections acquired by personal contact under particular 
‘modern’ socio-demographic circumstances (see Chapter 7). 
3.5 Conclusion
The incidence of ALL in Europe has slowly but continuously increased during 
the last two decades of the 20th century. This increase can only partly be 
explained by improvements in diagnostic methods and registration. 
In the Netherlands, a statistically significant increase of ALL has been seen 
during the last decade of the past century. Since the year 2000, however, this 
increase seems to have come to a halt, and has possibly been reversed. The same 
seems to apply to Belgium. The incidence of AML has remained relatively 
stable.
In the UK, it has been demonstrated that the geographical incidence of 
childhood leukaemia shows more clustering than would be expected if it were 
due to chance variations. This finding is consistent with the hypothesis that a 
non-random distribution of cases of leukaemia (i.e. clustering) could be due to 
the geographical distribution of environmental risk factors, including infectious 
agents. Incidence of childhood leukaemia 41
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4 Genetic factors
Although the focus of this report is on environmental risk factors for the 
induction and development of childhood leukaemia, the Committee briefly 
considers the role of genetics, primarily to demonstrate the complexity of the 
issue. Given this limited objective, a systematic search of the literature has not 
been undertaken, and an extensive review of the scientific data is not provided. 
First, the different genetic subtypes of childhood leukaemias will be described. 
Then two types of genetic susceptibility will be discussed.
4.1 Genetic subtypes
ALL and AML have distinct origins. They involve malignant transformation of 
lymphoid and myeloid progenitor cells*, respectively.2 Furthermore, for AML 
(~15% of cases) as well as for ALL of B-cell lineage (~70-75%) and T-cell 
lineage (~10-15%)**, many different subtypes can be distinguished, each 
characterised by specific genetic abnormalities.37 In Figure 5 the variation in 
age-specific incidence of different genetic subtypes of childhood leukaemia in 
the Netherlands is presented, starting in 1997.23
In the cord blood of healthy newborns the prevalence of a TEL/AML 
translocation (a preleukaemic lesion in circa 1:4 of ALL patients) is circa 1 in 
100, while only 1 in 10,000 will later in life develop ALL with TEL/AML.38,39
This forms an argument for a multistep pathogenesis: since at least 99% of the 
children with this ‘first hit’ will not develop leukaemia, there are more hits 
necessary to develop leukaemia. A recent international study revealed within 
families a high concordance of specific subtypes of childhood ALL, such as 
high-hyperdiploidy, indicating strong genetic or environmental risk factors for 
childhood ALL.40 
* A progenitor cell is a cell that, like a stem cell, has a tendency to differentiate into a specific type of 
cell, but is already more specific than a stem cell and is pushed to differentiate into its ‘target’ cell. 
The most important difference between stem cells and progenitor cells is that stem cells can replicate 
indefinitely, whereas progenitor cells can only divide a limited number of times.
** B-cells are lymphocytes produced in the bone marrow. The precursors of T-cells are also produced in 
the bone marrow, but they leave the bone marrow and mature in the thymus.Genetic factors 43
Figure 5. Age-specific incidence of childhood leukaemia by genetic and phenotypic subtype in the 
Netherlands (1997-2010). TEL/AML: B-cell Acute Lymphocytic Leukaemia (ALL) with TEL/AML 
fusion; HD: B-cell ALL with high hyperdiploidy (>50 chromosomes per cell); MLL: B-cell ALL 
with abnormalities including the mixed lineage leukaemia gene; T-ALL: T-cell ALL; ALLother: all 
other ALL; AML: Acute Myelocytic Leukaemia.
4.2 Genetic susceptibility
Different genetic abnormalities are at the origin of the different types of 
leukaemia. Childhood ALL is a multifactorial malignancy with age-specific 
deletions, insertions and chromosomal translocations.41 Genetic factors might 
influence the risk induced by environmental factors.42 
The aetiology of acute leukaemia in children is characterised by immature 
blood cells acquiring different consecutive genetic abnormalities. A 
susceptibility to these abnormalities occurring can be inherited. However, most 
abnormalities are acquired gene mutations in the genetic material of somatic 
(blood precursor) cells.
4.2.1 Inherited genetic susceptibility
Evidence
Strong evidence for a genetic susceptibility to childhood leukaemia is provided 
by the increased risk associated with particular genetic disorders, such as Down’s 
syndrome (trisomy 21).43 However, even in the absence of these predisposing 
conditions, a genetic susceptibility may contribute to the origin of childhood 
leukaemia. This genetic susceptibility is related to so-called genetic44 Childhood leukaemia and environmental factors
polymorphisms*.44
Until recently, studies looking for polymorphisms related to the risk of 
leukaemia generally used a ‘candidate gene’** approach in a case-control design. 
These candidate gene studies were evaluated in a systematic review and meta-
analysis.45 The authors identified significant associations between childhood 
ALL and eight polymorphisms. 
They mention, however, that numerous studies showed a defective 
methodological design and that their findings should be interpreted with caution, 
since the estimated ‘false-positive reporting probabilities’ for each association 
were considerable. Notably, none of the eight associations described in this meta-
analysis were identified in the ‘genome wide association studies’ by 
Papaemmanuil et al.46 Although some methodological issues might explain this 
discrepancy, it more likely underscores the proneness of identifying false 
positive associations in previous studies. Also, the genes studied in the candidate 
gene studies were often selected for practical reasons, because data were 
available from other studies, such as the relation between polymorphism and the 
toxicity of chemotherapy.
With the development of high throughput genotyping techniques, genome- 
wide association studies have become a feasible objective. In two landmark 
studies, using different genotyping platforms, strong susceptibility loci were 
identified.46,47 Genetic variation at these loci not only was associated with the 
development of ALL, but also with specific subtypes of ALL. The initially 
reported associations were verified in a replication study in precursor B-cell 
ALL, the most frequent type of ALL.48 
Although association studies might provide some mechanistic insights into 
the development of childhood leukaemia, the contribution of the described 
polymorphisms to leukaemic transformation remains unclear. Nonetheless, some 
studies convincingly have identified predisposing loci.49 However, modulation 
of the risk by environmental factors remains unexplored.
Public health relevance
Less than five per cent of childhood cancers reflect well-known hereditary 
cancer disposition syndromes.50 This means that more than 95% of children 
develop acute leukaemia in the absence of a predisposing syndrome.
* Polymorphisms: variations in genes.
** Candidate gene: gene with a biologically plausible function in the development of a specific disease.Genetic factors 45
4.2.2 Acquired genetic susceptibility
Evidence
In general, DNA abnormalities (gene mutations) play a major role in 
carcinogenesis.51 The vast majority of mutations in human tissues arise 
spontaneously and are due to endogenous factors. Only a small fraction of these 
acquired mutations, however, convert a normal cell into a cell that is initiated 
towards the development of cancer.52 
It is assumed that in most instances the initiation event is due to a mutation 
that may, for instance, cause inactivation or loss of a gene involved in the repair 
of damaged DNA. Another mechanism that may be involved in carcinogenesis is 
modification of gene expression by receptor binding or DNA methylation by 
specific chemicals. The regulation of gene expression by DNA methylation is a 
so-called epigenetic mechanism, for instance expressed as an enhanced 
proliferation of embryonal blood cells. The aetiology of leukaemia in children, 
especially ALL, is characterised by immature blood cells acquiring different 
consecutive genetic abnormalities, the first ones often occurring before birth.36,53
However, only few children who are born with a chromosomal translocation will 
develop ALL, proving that these are preleukaemic changes and that 
leukaemogenesis is multifactorial and depending on multiple consecutive events. 
The ‘first hit’, most likely acquired during pregnancy, will give rise to 
preleukaemic cells and clones being more susceptible to additional oncogenic 
events, the ‘second hit’. Most children with ALL carry 6 up to ~20 different 
genetic abnormalities in their leukaemia cells; in AML the number of genetic 
abnormalities is lower.54,55 The genes involved often play a role in the 
differentiation or proliferation of blood cells.
Although the causes of the oncogenic events remain largely unknown, the 
acquired genetic susceptibility is especially high during the first weeks of 
pregnancy, when parents might not even be aware of the pregnancy. This 
mechanism shows similarities with mechanisms in the development of 
congenital abnormalities, miscarriages, premature birth, intrauterine growth 
delay or other adverse pregnancy outcomes, since these are all related to cellular 
damage in the early development of the child. Depending on the phase of 
pregnancy in which the foetus is exposed to toxic agents, different outcomes may 
occur:
• Death of the embryo during the pre-implantation phase (first week).
• Malformations due to disturbed organ development (first trimester).
• Mental retardation due to disturbed development of the brain (first and 
second trimester).
• Increased risk of (childhood) cancer.46 Childhood leukaemia and environmental factors
Public health relevance
Genetic susceptibility factors, either separately or in conjunction with 
environmental factors, may be involved in the majority of childhood leukaemias 
that cannot be explained by identified specific genetic and environmental risk 
factors.56 In that respect, their relevance for public health is much greater than 
that of inherited genetic susceptibility.
4.3 Conclusion
Genetic polymorphisms might result in an increased vulnerability and therefore 
in a higher risk of developing childhood leukaemia. Most cases of childhood 
leukaemia result from a combination of (prenatal) initiation through the 
occurrence of genetic abnormalities and postnatal acquisition of multiple genetic 
abnormalities in haematopoietic progenitor cells.
Although the identification of genetic abnormalities has led to 
groundbreaking insights into the disrupted cellular pathways in leukaemic 
transformation, their origin is as yet unclear. However, insight into the genetic 
susceptibility of childhood leukaemia to risk factors is emerging, although the 
interaction with environmental factors is still largely unknown. Genetic factors 47
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5 Physical environmental factors
In this chapter the role of physical environmental influences on the induction and 
development of childhood leukaemia is discussed. The Committee evaluates the 
evidence on ionising radiation, extremely low-frequency magnetic fields, 
radiofrequency radiation and diagnostic ultrasound scans during pregnancy.  
5.1 Ionising radiation
5.1.1 Introduction
To evaluate the possible effect of ionising radiation on the incidence of childhood 
leukaemia, the Committee first discusses the evidence regarding ionising 
radiation in general. Since the exposure situations can show great variation, this 
is followed by a more specific evaluation, in which the Committee discusses five 
types of exposure, and assesses their possible contribution to the incidence of 
leukaemia in Belgium and the Netherlands:
• Natural radiation exposures.
• Medical radiation applications. 
• Parental occupational radiation exposure.
• Residential proximity to nuclear facilities.
• Radiation accidents.
These exposure situations have been selected either because they are relevant in 
terms of their contribution to the exposure of the Belgian and Dutch population 
to ionising radiation, or because of their relevance in policy and societal 
debates.57,58 
Types of ionising radiation
Ionising radiation is the scientific term for the phenomenon colloquially referred 
to as radioactive radiation or often, in short, as radiation. The term, however, 
covers various types of high-energy electromagnetic radiation and high-energy 
particles of subatomic dimensions. Examples of the former are X-rays generated 
by radiation machines and gamma rays emitted by radioactive substances. 
Examples of the latter are beta rays – electrons emitted by radioactive substances 
– and electron beams generated in so-called accelerators. Some radioactive 
substances emit positive electrons or positrons which also fall in the category of Physical environmental factors 49
ionising subatomic radiation; an important use of such substances is in positron 
emission tomography (PET scan). Other particle-type ionising radiations are 
alpha radiation – helium nuclei emitted by radioactive, heavy nuclei, e.g. radon – 
and neutrons released in nuclear fission or generated in particle accelerators.
Ionising radiation is applied in medicine for diagnostic and therapeutic 
purposes, in industrial radiography, in various forms of scientific research and in 
the production of electricity through nuclear energy. The radiation can be a by-
product, as with the release of radioactive substances into the environment by 
nuclear energy installations, but it also occurs naturally. As a result, all humans 
are exposed to cosmic radiation. When living at high altitudes and in aviation 
this type of exposure is increased. Furthermore, some radioactive substances are 
a natural part of the biosphere. Human exposure to these natural forms of 
radiation, however, depends on location and behaviour. Stony materials, for 
instance, have a much higher concentration of natural radioactivity than wood. 
The exposure to ionising radiation from natural radioactive substances is 
therefore quite variable.
5.1.2 Ionising radiation in general
Radiation dose
Ionising radiation manifests itself in a great variety of forms. Not all types of 
radiation and radiation energy have been studied in detail, neither 
epidemiologically nor in the laboratory, either in relation to cancer in general or 
leukaemia in particular. However, the general scientific view is that what holds 
for one type of radiation also holds for another, at least in a qualitative sense.59 
Central in this view is the absorption of radiation energy resulting in 
ionisation events that directly or indirectly affect biologically sensitive 
molecules, in particular DNA. Radiation exposure can be quantified in terms of 
an ‘equivalent dose’*, using sievert (Sv) as a unit. It is generally assumed that the 
risk of radiation exposure with DNA as a target is proportional to the absorbed 
energy, i.e. the equivalent dose. However, recent research has indicated that other 
mechanisms that do not directly affect DNA may cause harm as well.61 Whether 
these effects are proportional to the equivalent dose is as yet uncertain.
In describing the exposures of populations, the quantity ‘effective dose’ is 
commonly used.** In the case of a (more or less) uniform exposure of the body, 
the effective dose is equal to the whole body equivalent dose. In the case of non-
uniform exposure, for instance after ingesting radioactive substances, the 
* Equivalent dose: the quantity of radiation energy absorbed at a certain point in the body per unit 
mass, adjusted for the biological effectiveness of that specific form of radiation.60 1 sievert (Sv) 
corresponds to 1 J⋅kg-1. 
** Effective dose: a whole body equivalent dose corrected for differences in radiosensitivity related to 
cancer induction between the various organs and tissue.6050 Childhood leukaemia and environmental factors
effective dose is taken to represent a similar cancer risk as in the case of uniform 
exposure.
For leukaemia, the exposure of the lymphatic system, and in particular the 
red bone marrow, is assumed to be especially relevant. The exposure quantity is 
therefore usually established to be the equivalent dose to the red bone marrow. 
For external exposures to ionising radiation, e.g. from cosmic rays or gamma 
rays from natural radioactivity in soil and building materials, this quantity can be 
equated to the exposure of the whole body. However, after the inhalation or 
ingestion of radioactive substances the exposure of the body is not uniform. In 
that case, the bone marrow equivalent dose has to be derived from complex 
calculations, taking into account the distribution and fate of the radioactive 
substances in the body.62-68 The available information on the relation between 
exposure to ionising radiation and leukaemia includes the exposure of embryo 
and foetus after the intake of radioactive substances by the pregnant mother, and 
the doses from ingestion of radioactive substances with mothers’ milk. The 
Committee, however, stresses that such data should not be used uncritically, 
since the calculations are based on biokinetic models that might change as more 
becomes known about the way substances are transported through the body, and 
how they are transformed and retained in the various organs. An example is the 
model used to calculate the exposures from noble gases. It uses irradiation of the 
skin or of the whole body (depending on the radiations emitted), but does not 
take into account inhalation and absorption in the lungs, nor the solubility in 
body fat. 
Another reservation is in order. Even though the equivalent dose concept is 
commonly used to estimate radiation risk and to derive standards for radiation 
protection purposes, some doubt exists as to whether this concept is fully 
applicable in the exposure regimes generally encountered in the environment, in 
the work place and through medical diagnostic procedures. Given the present 
insights in radiation disease mechanisms, however, it has so far not been possible 
to propose a new or adjusted concept.
Epidemiological evidence
X-rays and radioactive substances were discovered at the end of the 19th century. 
Not long afterwards, indications of negative health impacts became apparent.69
‘Radiation workers’ lost part of their hair and complained about burned skin and 
vomiting.70 In the first decades of the 20th century, cases of cancer were observed 
and related to the, often high, radiation exposure of radiation workers. A first 
report of leukaemia after prolonged exposure to radiation is dated 1911.70 
In the course of the years, evidence has been gathered about the negative 
health impacts of ionising radiation at much lower exposure levels. Pertinent 
information about the health risks of ionising radiation exposure was obtained 
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Japanese cities of Hiroshima and Nagasaki at the end of World War II.71 Also, 
follow up studies of populations that were irradiated for medical purposes and of 
occupationally exposed populations have provided information about radiation 
risks. From these research data, and the evaluations by international and national 
scientific committees, evidence has emerged on the relationship between 
ionising radiation exposure and the incidence of childhood leukaemia. The 
Committee will use this information as a basis for its conclusions. 
It is not scientifically disputed that ionising radiation exposure may cause 
leukaemia. An exception is the occurrence of (adult) chronic lymphatic 
leukaemia where radiation does not appear to play a role.72 The Biological 
Effects of Ionising Radiation Committee (BEIR) of the US National Academy of 
Sciences has established relationships between radiation exposure and the 
incidence of leukaemia in the US population as a function of the age when 
exposure occurred and the time lapsed since the exposure, using the atomic bomb 
survivor data in Japan as a basis.73 The so-called latent period, between the time 
of exposure and the time of increased leukaemia risk, lasts a few years. After a 
further period of five years, the risk tends to decrease. 
The age at which exposure occurs appears to be relevant: the lower the age at 
the time of exposure, the higher the lifetime risk.74 Furthermore, after prenatal 
medical exposure through irradiation of the mother and medical exposure of 
young children, increased risks of childhood leukaemia have been 
observed.59,70,72,75,76 
Other evidence
Experimental studies, i.e. laboratory research with cell lines and experimental 
animals, have provided insight in the mechanisms that operate on the pathway 
from exposure to disease. From the evidence gathered, it has become clear that 
exposure to ionising radiation has the potential to, directly or indirectly, affect the 
genetic information (DNA) in the nuclei of the cells in the body, which may lead 
– sometimes after many years – to cancer, including leukaemia. 
Damage to germ cells may lead to hereditary diseases, while in utero 
irradiation can cause congenital malformations and other damage.59 Whether 
direct or indirect processes at a cellular level, or both, affect the genetic 
properties of cells, is at present a matter of discussion.77,78 The foetus and the 
infant may be particularly vulnerable, given the relatively rapid division and 
multiplication of cells in the growing organism. 
An important issue is whether exposures to ionising radiation at the low levels 
and rates encountered normally in the environment and in the work place may 
also lead to an increased risk of cancer, hereditary effects or other disease.78,79
Mainly based on experimental studies, international review committees have 
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exposure threshold below which the risk would be nil.60,78 The Committee feels 
that, with respect to radiological protection measures and policies, this 
interpretation of the available evidence is a prudent option. It will therefore 
follow this approach in its discussion of the relation between the risk of 
childhood leukaemia and exposure to ionising radiation. 
The precise nature of the relationship between low level exposures and health 
effects, in particular the risk that cancer will occur, is, however, not well 
known*.80 Based on insights in the processes leading to cancer, a linear 
relationship between radiation exposure quantities and cancer risk is widely 
assumed.60,79 However, there are indications that this relationship may in some 
situations underestimate the risk associated with radiation.81 Furthermore, 
research into the inter- and intracellular processes challenges the linear non-
threshold model for cancer induction, and raises the possibility of protective 
responses at relatively low exposure (below 100 mSv).82 
However, the newer findings so far have only added complexity, suggesting 
both overestimation and underestimation of the risks at low doses, making it 
difficult to propose a better model.80
Evaluation
Following the UNSCEAR** and other international review committees, the 
Committee regards the findings from epidemiological research and research into the 
mechanisms of cancer inductions as evidence for the claim that exposure to 
ionising radiation of the foetus and of young children can cause childhood 
leukaemia. The Committee denotes the level of evidence for a causal relationship 
between exposure to ionising radiation and childhood leukaemia from both 
epidemiological research and laboratory research as established.59,72,75
5.1.3 Natural radiation exposures
The exposure (average effective dose) to natural ionising radiation from cosmic 
origin, from radioactive substances in soil and building materials, and from 
natural radioactive substances in the body (not including the contribution from 
inhaled radon decay products) is about 1 millisievert (mSv) per person per year 
both in Belgium and in the Netherlands.58 This exposure is quite uniformly 
distributed over the body and therefore the bone marrow equivalent dose 
(relevant for leukaemia) is equal to the effective dose. In the Netherlands, people 
are rather uniformly exposed throughout the country. In Belgium, exposures in 
* The data of the Japanese atomic bomb survivors suggest a linear-quadratic exposure-response 
relationship for leukaemia74. However, for the exposures commonly encountered in the present day 
environment or at work a linear relationship, extrapolated downwards from the epidemiological data, 
is also not inconsistent with the data.
** UNSCEAR: United Nations Scientific Committee on the Effects of Atomic Radiation.Physical environmental factors 53
the South are higher than in the North, due to higher concentrations of 
radioactivity in the soil.57 The maximum difference is about 0.6 mSv per person 
per year. A population group receiving relatively high exposures to cosmic 
radiation is aircraft personnel (see 5.1.5).
Decay products of the noble gas radon are radioactive forms of polonium, 
bismuth and lead*. Radon is released by soil and stony building materials. The 
decay products get attached to airborne dust particles. When inhaled, they may 
be deposited in the lungs, and after absorption they may irradiate other organs. 
Due to radon accumulation in dwellings, exposure is considerably higher indoors 
than outdoors, and will depend on ventilation (replacement of indoor air by 
outdoor air), the degree to which radon from the basement or crawl space may 
diffuse into the living quarters and the choice of building materials. 
Radon concentrations in dwellings in the Netherlands amount on average to 
30 Bq⋅m-3 **, with building materials as the main contributor (about 70%).85 The 
variation from dwelling to dwelling is relatively small from an international 
perspective; concentrations above 100 Bq⋅m-3 are quite exceptional. 
In Belgium, the situation is different. The average concentration in dwellings 
is about 50 Bq⋅m-3, whereas in the South concentrations above 400 Bq⋅m-3 are 
found in a substantial fraction of the dwellings.57,86 The contribution from the 
soil below a dwelling is much more important in Belgium than in the 
Netherlands. 
However, the contribution of the inhalation of radon and radon decay 
products to bone marrow dose is quite uncertain. Estimates of bone marrow 
equivalent doses vary from 0.1 to 1 mSv per year at an exposure concentration of 
200 Bq⋅m-3.87 This means that for the average radon concentrations, the bone 
marrow equivalent dose may vary in the Netherlands from 0.015-0.15 mSv, and 
in Belgium from 0.025-0.25 mSv. 
Epidemiological evidence
Except in the case of radon exposures, the Committee is not aware of research 
that has specifically investigated the relationship between natural background 
radiation and childhood leukaemia. Several studies did compare leukaemia 
incidence or mortality in areas with different natural radiation exposure due to 
differences in radioactivity in the soil.59 Even though some studies included quite 
large populations (several tens of thousand), generally no statistically significant 
differences were found between the ‘high’ and ‘low’ exposure regions. However, 
other genetic and environmental factors may have played a role that could not be 
accounted for. 
* Two radioactive forms of radon exist that are denoted somewhat confusingly as ‘radon’ and ‘thoron’. 
In view of possible health effects – mainly lung cancer – ‘radon’ is of primary importance, although 
in the Netherlands recently the contribution of ‘thoron’ has also been investigated.83,84
** The unit of radioactivity is becquerel (Bq). 1 Bq equals one disintegration per second.54 Childhood leukaemia and environmental factors
Regarding the exposure to radon decay products, a recent review has 
summarised data from ecological and case-control studies on the association 
with childhood leukaemia.88 By applying a meta-analysis, a statistically 
significant increased risk for indoor radon exposure was noted for ALL and for 
childhood leukaemia in general. However, the authors concluded that more 
evidence is required to confirm this association.
Evaluation
The Committee concludes that the epidemiological evidence for an association 
between environmental radon exposure and childhood leukaemia is limited. It is, 
however, consistent with an assumed causal relationship with naturally occurring 
ionising radiation exposure. 
Public health relevance
For Great Britain, the contribution of natural radiation exposure to the incidence 
of childhood leukaemia has been estimated at 15-20%.89-91 This estimate is based 
on risk data derived from the studies on Japanese atomic bomb survivors, and 
various models.72,73,92 It should, however, only be used as an indication. 
Recently, a large case-control study in Great Britain supported the extrapolation 
of high-dose rate risk models to protracted exposures at natural background 
exposure levels.93 There appeared to be 12% excess relative risk of childhood 
leukaemia per mSv of cumulative red bone marrow dose from gamma radiation, 
insensitive to adjustment for socio-economic status.
Given the similarity of exposure in Great Britain to that in Belgium and the 
Netherlands, the Committee assumes that similar calculations for Belgium and 
the Netherlands would lead to an estimate of the same magnitude. 
Recommendations
In seeking policy measures to protect against natural radiation exposure with the 
aim to reduce lung cancer, the focus has mainly been on building construction 
(subsoil and crawl space ventilation) and the choice of building materials. In this 
way, exposure to radon and its decay products originating from soil and building 
materials may be reduced. Especially in dwellings in the south of Belgium, the 
radon concentrations are relatively high. Knowing this, the Belgian authorities 
have been providing information on measures that may help reduce this 
exposure.86 In the north of Belgium and in the Netherlands, the possibilities for 
exposure reduction are more limited, although some decrease may still be 
possible by using building materials with low radium and thorium content, and 
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Where radon is concerned, the main public health argument for taking 
measures is its impact on the occurrence of lung cancer. However, a reduction in 
exposure may also contribute to a decrease in the incidence of childhood 
leukaemia, but this would be expected to be limited. 
5.1.4 Medical radiation applications
Medical applications of ionising radiation encompass diagnostic investigation 
and therapeutic treatment. The main purpose of radiotherapy is to destroy tumour 
cells. This means that at the tumour location radiation exposures are quite high, 
amounting to equivalent doses of 10 Sv or more. Inevitably, other tissues, 
including bone marrow, are also exposed, albeit to a much lesser extent. As has 
been mentioned above, studies on therapeutic exposure have provided data about 
the relationship between ionising radiation exposure and childhood 
leukaemia.72,75 
The population exposure from diagnostic applications of imaging techniques 
has increased quite strongly.79,95,96 An important driver for the recent increase is 
the use of computed tomography (CT) scans, which, by providing three-
dimensional images, has considerable medical advantages, but which has also 
led to an increase of exposure, in terms of the number of examinations as well as 
an in the exposure per examination as compared to classical radiography.97,98
With new digital imaging opportunities presenting themselves (such total body 
CT, cone beam CT, hybrid technology), and given market trends, expanding use 
of CT could further increase medical exposure substantially.
In 2009, the effective dose due to medical applications of ionising radiation 
(mainly diagnostics) was about 0.9 mSv per person per year, averaged over the 
whole population, in the Netherlands.99 As compared with 2005, the exposure 
has nearly doubled, mainly due to CT scans. In Belgium, medical radiation 
exposure was considerably higher than in the Netherlands. The corresponding 
population average effective dose was 1.7 mSv in 2003 and 1.9 mSv in 2007.100 
As radiographic exposures are not uniformly distributed over the body, the 
bone marrow equivalent dose will be different from the effective dose. However, 
the Committee considers that the numbers given above should be indicative of 
the bone marrow dose (per person per year, averaged over the whole population).
Because of the high radiosensitivity of red bone marrow in childhood, 
prenatal exposure and postnatal exposure in the first years of life are especially 
relevant. However, exposure data, specifically for prenatal exposure, are almost 
not available. 
World-wide data collected by UNSCEAR for the period 1997-2007 resulted 
in an estimate of 3-10% of children in the age group of 0-15 years exposed to 
various radiographic examinations.101 From an analysis of Dutch insurance data, 
it may be concluded that the frequency of these examinations strongly increases 56 Childhood leukaemia and environmental factors
with age.102 This implies that average exposures later in life are higher than those 
at a younger age.
Epidemiological evidence
Epidemiological studies indicate that maternal exposure to X-rays during 
pregnancy is associated with childhood leukaemia.75,76,103 
Recently, the authors of a retrospective cohort study concluded that the use of 
CT scans in children and young adults (<22 years of age) may almost triple the 
risk of leukaemia.104 Data on the leukaemia risk related to frequent X-ray 
exposures during neonatal intensive care is lacking.
Evaluation
The Committee concludes that the epidemiological evidence on medical 
radiation exposures lends support to the general conclusion that ionising 
radiation may cause childhood leukaemia.
Public health relevance
Radiotherapeutic exposures of children may cause secondary cancers, including 
leukaemia. As childhood cancer is relatively rare, the absolute number of cases will 
be small as compared to the total number of childhood leukaemias in Belgium and 
the Netherlands. From the scarce data on prenatal and postnatal (mainly diagnostic) 
medical exposures, the Committee concludes that the contribution nonetheless is 
relevant. However, any quantification of the risk is at present not possible. 
Recommendations
Exposure to radiation for medical purposes needs to be justified, both 
collectively (is the method as such justified?) and individually (is the patient’s 
examination or treatment justified?). The individual justification is the primary 
responsibility of the referring medical practitioner. Although clinical benefits 
should outweigh the small absolute risks, radiation doses, specifically from CT 
scans, ought to be kept as low as reasonably achievable (ALARA*), and 
alternative procedures which do not involve ionising radiation should be 
considered.104
It is broadly accepted that medical diagnostic exposures can often be reduced 
by increasing risk awareness among medical practitioners, and by applying 
‘optimisation’ and diagnostic reference levels, without losing diagnostic 
* ALARA (As Low As Reasonably Achievable): a principle intended to guide action to reduce 
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advantages.79,96,105-107 The Superior Health Council in Belgium suggested to 
improve risk awareness of medical staff in order to better manage the risk related 
to digital imaging.96 The Committee strongly supports this view and is of the 
opinion that it also needs to be applied with respect to prenatal and postnatal 
exposure, in view of the increased leukaemia risk*. 
First and foremost, the choice of an imaging technique is important, 
weighing the diagnostic benefits against potential harms. The use of techniques 
that do not involve ionising radiation (magnetic resonance imaging, ultrasound) 
should always be considered, especially where pregnant women, infants and 
young children are concerned. A susceptible subgroup that may require special 
attention are prematurely born children.109,110 As neonatal chest images are 
frequently required to investigate life-threatening lung diseases, optimisation in 
terms of X-ray exposure is necessary. Health care professionals may contribute 
to this cause by developing better techniques for radiology in children**. 
Furthermore, practitioners need to discuss the risks of radiation exposure with 
patients. 
To resolve gaps in knowledge, there is a need for more detailed and more 
precise data on the exposure of unborn children and infants, including subgroups 
such as prematurely born children, in order to apply dose reduction strategies for 
X-ray examinations in pregnant women and infants. In addition, research is 
needed on the biological effects of pre- and postnatal diagnostic X-ray exposure 
in general and exposures from CT scans in particular.
5.1.5 Parental occupational radiation exposure
In various occupations workers are exposed to ionising radiation. In terms of 
average radiation exposure, the most important occupations are the nuclear 
industry (from mining to waste treatment), health care and industrial 
radiography.111 The average registered effective dose of monitored workers in 
the Netherlands in 2004 was 0.6 mSv per person. 
Although the average registered individual occupational exposure is 
generally low (an effective dose of 1 mSv or less), there are groups with much 
higher individual exposures. Examples are interventional cardiology personnel 
and groups of workers in nuclear power plants.111
Aircraft crews have also been identified as being occupationally 
exposed.60,112-114 Depending on the nature of the flights, geographical location 
and the number of hours in the air, the increased exposure (effective dose) to 
* The Committee draws attention to an initiative in a quality improvement program for CT scans in 
children, an on-line learning tool for radiologists: the ‘Image Gently’ Campaign of The Alliance for 
Radiation Safety in Pediatric Imaging.108 The Federal Agency of  Nuclear Control in Belgium is a 
member of The Alliance.
** In 2012, the Dutch Health Inspectorate started a project on radiology in children. The aim is to 
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cosmic radiation may amount to several mSv per person per year*.115 The 
average effective dose for aircraft crew members in the Netherlands in 2004 was 
1.5 mSv. This is comparable to Belgium, where average values of 1.3-1.6 mSv
were established in the period from 2008 to 2010.116 
Given the established relation between exposures to ionising radiation and 
childhood leukaemia and the fact that leukaemia can arise prenatally, exposure of 
radiation workers was studied as a potential risk factor for the development of 
childhood leukaemia in the offspring.
Epidemiological evidence
An epidemiological study on childhood leukaemia in the vicinity of the 
Sellafield nuclear complex (UK) showed an association with preconceptional 
occupational exposure of the fathers of children with the disease.117 The findings 
were not confirmed, however, in further studies. The present consensus is that 
this exposure pathway is unlikely to explain the original association between 
childhood leukaemia in Sellafield and paternal preconceptional irradiation.90 In a 
national record linkage case control study in the UK, excluding the Sellafield 
cases, the significantly increased risk of leukaemia among children of male 
radiation workers appeared not to be related to their preconception radiation 
dose.118 Indeed, the association was greatest for the group with zero dose or 
doses below the level of detection.
The same study did not indicate that children of female radiation workers 
have a significantly increased risk of developing leukaemia.118,119 The 
Committee is not aware of other epidemiological data on childhood leukaemia in 
relation to pre- and postconceptional occupational radiation exposure of women, 
including aircraft crew.
Evaluation
The Committee concludes that the epidemiological evidence for an association 
between parental occupational radiation exposure and childhood leukaemia is 
inadequate.
Public health relevance
On a population level, the contribution of occupational exposure to the incidence 
of childhood leukaemia will be quite small, because of the number of parents 
involved in work where exposure occurs and due to the radiation protection 
measures and the relatively low exposures.
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Recommendations
Occupational radiation exposure of pregnant women needs to be restricted. 
According to European regulations, exposure of the foetus should be less than an 
equivalent dose of 1 mSv, and registered radiation workers are obliged to declare 
a pregnancy to their employer.112 Many employers then shift pregnant radiation 
workers to an alternate job, in which no exposure occurs.
Because of the potential risks of radiation exposure during the first weeks of 
pregnancy, the Committee recommends radiation workers and aircraft personnel 
to also notify their employer of the intention to get pregnant. In any case, 
employers should adhere to the accepted approaches for reduction of radioactive 
exposures, such as ALARA, and employees should be aware of the relevance of 
preconceptional care. 
5.1.6 Residential proximity to nuclear installations
The possibly increased incidence of childhood leukaemia near nuclear 
installations is a recurrent social issue*.6,121 The most recent input were the 
findings in a French study that reported a possible excess risk of acute leukaemia 
in children in the close vicinity of French nuclear power plants.122
Epidemiological evidence
Many studies have been performed to gain clarity on the relationship between 
living near nuclear installations and childhood leukaemia. One of the reasons for 
such studies came from observing clusters of childhood leukaemia cases near 
these installations. The research hypothesis usually is concerned with 
radioactivity released into the local environment, exposure to which might lead 
to an increase in health risks in general, and to a higher cancer and leukaemia 
risk in particular. 
A recent report of the British Committee on Medical Aspects of Radiation in 
the Environment (COMARE)123 refers to two reviews124,125 that performed a 
meta-analysis by combining data from different studies. From the analysis of 
release data from nuclear power plants in the UK, France, Germany and 
Switzerland, COMARE concluded that equivalent doses related to radioactive 
releases are too low to explain a possible increase in leukaemia risk, given the 
present understanding of the biological impact of ionising radiation. It also 
rejected suggestions that the risk from exposure of the foetus to released tritium 
* The issue was preceded by a debate on a fall-out related increased mortality of babies and young 
children due to the atmospheric atomic bomb tests.120 Such claims were refuted in the course of the 
years, but, with the expansion of nuclear electricity production, the discussion reignited and focused 
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and radioactive carbon (as suggested by Fairlie126) could be much higher than 
currently assumed.123 
Using the terminology the Committee has chosen in this report, COMARE 
can be said to conclude that the evidence for an epidemiological association 
between an increased leukaemia risk and a release of radioactivity in the local 
environment is inadequate, and that the higher incidence cannot be explained by 
airborne radioactive exposure. Therefore no evidence is known for a causal 
relationship. 
The German Commission on Radiological Protection 
(Strahlenschutzkommission) has drawn a similar conclusion, based on the 
German KiKK* study.127,128 A systematic review of French researchers was also 
unable to draw a conclusion about a possible cause for the increased incidence of 
childhood leukaemia sometimes observed in the vicinity of nuclear power 
plants.129 
Recently, the results of an investigation into the incidence of childhood 
leukaemia and thyroid cancer in Belgian communities near nuclear installations 
became available.130 Results showed no increase in the incidence of acute 
childhood leukaemia within a circle of 20 kilometers around five nuclear 
installations, except for one. In the latter site the incidence was higher than the 
national average, however based on a relatively small number of observed cases 
(n=21). Dose-response analyses were hampered by the relatively large size of the 
smallest administrative level at which cancer data are available in Belgium. 
Therefore it was recommended to participate in international collaborative 
initiatives to pool data on childhood leukaemia. 
A problem in all these investigations is that the exposure of members of the 
population under study was not measured. Therefore, many studies used the 
distance from a dwelling to the nuclear installation as an exposure proxy, 
carrying out model calculations based on data of estimated releases of radioactivity 
as declared by the operator of the installation. These usually resulted in very low 
exposures. On this point, the Committee wishes to remark that the releases of noble 
gases from nuclear installations may vary by more than a factor 100, and that 
more or less instantaneous accidental releases of noble gases, often not registered, 
may be of more importance than the average annual release reported by nuclear 
installation operators. In addition, exposure quantities other than the usual 
equivalent dose may be more relevant in studying an association between 
childhood leukaemia and nuclear installations. 
Evaluation
The Committee concludes that at present, the increased risk of childhood 
leukaemia near some installations, observed in some studies, has not been 
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explained satisfactorily. Exposure to radioactive emissions seems an unlikely 
explanation, but uncertainties remain, especially with respect to the relevant 
exposure quantity and pattern.
Public health relevance
If there would indeed be an increased risk of childhood leukaemia when parents 
and young children live near a nuclear installation, the total number of cases in 
Belgium and the Netherlands will most likely be very small as compared to the 
total number of cases of childhood leukaemia in each country. 
Recommendations
It is questionable whether the issue of a relationship between childhood 
leukaemia and living in the vicinity of a nuclear installation can be resolved by 
further epidemiological research, as long as meaningful exposure quantities (for 
radiation or other factors) have not been identified. Still, the Committee proposes 
to monitor the emissions of radioactive noble gases from nuclear installations, 
and to study locations that differ in the way emissions of radioactive noble gases 
are handled and locations with accidental releases of radioactive noble gases. 
It might also be helpful to pool epidemiological data on potential risk factors 
related to the vicinity of nuclear power plants at an international scale, as has 
recently been proposed on the basis of studies in France and Belgium.122,130,131 In 
any case, operators should adhere to the accepted approaches for reduction of 
radioactive emission, such as ALARA, using the best available techniques.
5.1.7 Radiation accidents
A recent UNSCEAR report listed about 350 radiation accidents.132 The accidents 
are not limited to one sector, but occur with all applications of ionising radiation. 
Some are rather localised and involve overexposure of a few people, others may 
have impact on a much more extended scale, such as in the case of the Chernobyl 
accident in 1986.133 In addition, criminal use of radiation has been reported. 
According to UNSCEAR, medical radiation incidents and accidents might be 
underreported. 
Localised accidents leading to high radiation exposures may locally cause 
severe radiation sickness and death. In the case of accidents with a more 
extended release of radioactive substances into the environment, the exposures 
are much less, in any case at larger distances from the release point. In those 
situations, the question about a possible contribution to the incidence of 
childhood leukaemia arises. In Belgium and the Netherlands this was the case 
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Epidemiological evidence
The consequences of the Chernobyl accident have been reviewed by UNSCEAR 
several times, most recently in 2008.134 UNSCEAR concluded that 
epidemiological studies among the population in the most severely contaminated 
areas in the Ukraine, Belarus and Russia showed an increased incidence of 
thyroid cancer, but not of other types of cancer. However, a more recent report 
described an increase in childhood leukaemia cases (ALL and particularly AML) 
in the most severely contaminated areas of the Ukraine.135,136 However, there is 
uncertainty about the quality of the data and therefore about the magnitude of the 
radiation risk.137
Evaluation
Based on an increase in childhood leukaemia cases in the most severely 
contaminated areas of the Ukraine, the Committee concludes that the evidence 
for an association between exposure from radiation accidents and childhood 
leukaemia in general is limited. 
Public health relevance
In Belgium and the Netherlands, the exposure to radioactive substances released 
in the Chernobyl accident is not reflected in increased cancer risks observable 
from cancer registers or dedicated epidemiological research. In low exposed 
European countries such as Belgium and the Netherlands (average whole-body 
dose <0.2 mSv) the attributable fraction of all leukaemia cases, including 
childhood leukaemia cases, due to radiation exposure from the Chernobyl 
accident has been estimated at about 0.01%.138 This is too low to be detected 
epidemiologically. This study contradicts the conclusions of an earlier report that 
Chernobyl fallout could well have caused a small, but significant excess of 
childhood leukaemia cases in Europe, in view of the excess cases in the birth 
cohort exposed in utero.139
Looking at a population level, the Committee adheres to the view that the 
impact of remote accidents where ionising radiation was released on an extended 
scale, as was the case in Chernobyl, has been undetectable in Belgium and the 
Netherlands. Local accidents, however, will always incur some risk, dependent 
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5.1.8 Overall conclusions and recommendations
Conclusion
On the basis of epidemiological and laboratory research as reviewed by 
international and national expert committees, the Committee concludes that 
prenatal and postnatal exposure to ionising radiation contribute to the incidence 
of childhood leukaemia. Because of this, the Committee considers a causal 
relation between exposures to ionising radiation and childhood leukaemia as 
established.
In addition, the Committee supports the view expressed by several 
multidisciplinary Committees of scientists that this holds for all types of ionising 
radiation, and that there is no exposure threshold below which an increase in 
leukaemia risk is absent.59,60,73,78,79 
Of the specific exposure situations considered, the Committee believes that 
exposure to natural radiation may provide a non-negligible contribution to the 
incidence of childhood leukaemia. Exposure for medical reasons and the 
projected increase in this area, especially from CT scans for diagnostic purposes, 
is a specific matter of concern. Other widespread types of exposures, e.g. those 
of pregnant passengers and young children during flights, are thought to 
contribute only marginally to the risk of childhood leukaemia, both individually 
and on a population level.
Recommendations
Despite the overall risks being small, exposure reduction is warranted in the 
medical as well as in the environmental and occupational fields, not only to 
reduce childhood leukaemia, but also to reduce the occurrence of other adverse 
health effects.
The possibilities for the reduction of exposure to ionising radiation will vary 
in different situations, and will also vary in Belgium and the Netherlands. 
Notwithstanding the large uncertainties, the contributions of natural and medical 
sources of ionising radiation exposure are the most relevant, and a reduction in 
the exposure to these sources may be expected to decrease the risks. Effective 
ways to achieve this may be: stricter justification standards and optimisation 
procedures for medical exposures, further reduction of emissions from nuclear 
installations and continuing or intensifying radon reduction programmes. The 
Committee emphasises that exposure reduction is not only important for 
leukaemia, but also for other forms of cancer and other diseases associated with 
exposure to ionising radiation.64 Childhood leukaemia and environmental factors
5.2 Extremely low-frequency (ELF) magnetic fields
Exposure to ELF magnetic fields is highly dependent on location and time. 
Major indoor sources are the indoor electricity system and electrical appliances. 
Magnetic fields are only generated when current flows, and their strengths are 
therefore directly dependent on appliance use. The fields decrease in general 
with the square or the 3rd power of distance, so the magnetic field strength may 
vary considerably over short distances. 
The primary external source in Belgium and the Netherlands are overhead 
high voltage power lines. Their contribution to total exposure is relevant within a 
distance of up to approximately 150 m from the line, and also depends on the 
amount of current transported and the voltage on the line. Since the first report 
suggesting an association between living in the vicinity of power lines and 
childhood leukaemia was published in 1979, dozens of increasingly sophisticated 
studies have examined the possible association with exposure to ELF magnetic 
fields.140
Evidence
Based on consistent associations found in individual epidemiological studies and 
the results from two pooled analyses, in 2002 IARC classified ELF magnetic 
fields as ‘possibly carcinogenic to humans’ (group 2B: see Annex F).140 In 2007, 
a WHO expert task group concluded that consistent epidemiological evidence 
suggests that chronic exposure to low-intensity ELF magnetic fields (≥0.4 μT* as 
compared to <0.1 μT) is associated with an increased risk of childhood 
leukaemia.18 Both major reviews were taken into account in both Evidence 
Summaries of systematic reviews.213,225 A drawback of both reviews, however, 
is that the residential exposure to ELF magnetic fields was not defined uniformly. 
It varied from 24-hour or instantaneous measurements in one or more rooms, 
distance and relative load for power lines to exposure from different electrical 
appliances.18,140 
The results of a more recent pooled analysis by Kheifets et al. of seven 
studies published since 2000 are in line with the outcomes of previous pooled 
analyses, which showed an association between measured or calculated magnetic 
fields and childhood leukaemia in general.141 The association seems weaker in 
the most recently conducted studies, but these are small and lack the 
methodological improvements needed to clarify the apparent association. 
Although some experimental studies report effects of ELF on mutation 
frequency and gene expression, the WHO task group concluded that there is 
limited evidence for a causal relation.18
* The strength of magnetic fields is expressed in the magnetic flux density in microtesla (μT).Physical environmental factors 65
Evaluation
Many epidemiological studies have focussed on the association between 
residential exposure to ELF magnetic fields from power lines or electric 
appliances and childhood leukaemia. Most of these have considered childhood 
leukaemia in general; consequently separate information on ALL and AML is 
very limited. Since more than 80% of childhood leukaemia is ALL, the 
Committee considers the association to be applicable to this most common form, 
although it cannot be ruled out that the association could be due to a combination 
of selection bias and confounding.14,142 Therefore, the Committee considers the 
epidemiological evidence for an association between exposure to ELF magnetic 
fields and ALL (and childhood leukaemia in general) sufficient, whereas for 
AML it is characterised as inadequate.
The epidemiological findings are insufficiently supported by results from 
experimental studies and by mechanistic insights into causality, which means 
that the plausibility of there being a biological mechanism should be considered 
low. 
Based on the available evidence from these two types of research, the 
Committee considers a causal relation between exposure to ELF magnetic fields 
and ALL or childhood leukaemia in general as possible, whereas the existence of 
a causal relation between ELF magnetic fields and AML is unknown.
Public health relevance
The number of children exposed to ELF magnetic field levels above which an 
increased risk of childhood leukaemia is observed in epidemiological studies 
(exceeding 0.4 µT) is small. A survey in Belgium indicated that the prevalence of 
children exposed to at least 0.4 µT is approximately 1.4% for modelled exposure 
from overhead power lines and 4% for measured exposures from power lines and 
other sources.143 
No such data are available for the Netherlands. For the Netherlands it was 
calculated in 2003 that approximately 11,100 children live in areas near overhead 
high power lines where the magnetic field strengths exceed 0.4 µT.144 Assuming 
a total number of children up to age 15 of approximately 3 million, the exposure 
prevalence in the Netherlands is approximately 0.4%.144,145 Ahlbom et al. 
calculated a relative risk for exposure levels of at least 0.4 µT, compared to levels 
of less than 0.4 µT, of 2.00 (95% confidence limits 1.27-3.13).146 
Combining these data into the formula given in section 2.3 of this report 
results in a population attributable fraction (PAF, expressed as a percentage) for 
Belgium of 1.38 (0.38-2.90)% for modelled and 3.85 (1.10-7.85)% for measured 
exposures and for the Netherlands a PAF of 0.40 (0.11-0.84)% for modelled 
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individual risk to develop leukaemia for children in the Netherlands was found to 
be 3x10-5 per year.144,145 
Considering that an incidence of 3.8 per 100,000 was used, these data pertain 
to ALL only. This means that, if a causal relation exists, and given a total of 
approximately 110 new ALL cases each year, the number of extra cases of ALL 
attributed to magnetic exposures from high voltage power lines in the 
Netherlands is estimated at 0.4-0.5 per year.144
Recommendations
If the relation between exposure to ELF magnetic fields and childhood 
leukaemia would be causal, its impact is likely to be small at the level of the 
general population. However, in situations where children are long-term exposed 
to magnetic fields exceeding approximately 0.4 µT it might be relevant. This 
warrants taking precautionary measures for these high-risk groups to reduce 
exposures.8
5.3 Radiofrequency radiation
In the past decades, exposure of the population to radiofrequency 
electromagnetic fields (RF EMF) has been ubiquitous. Radio- and television 
transmitters have increased in number and become more powerful. The rise of 
mobile telephony has added another layer of RF EMF to society. Several studies 
have investigated a possibly increased incidence of childhood leukaemia near 
sources of RF EMF.
Evidence
No systematic reviews on the association between radiofrequency radiation and 
childhood leukaemia have been identified. Individual studies are all hampered by 
difficulties in assessing the exposure. This is especially problematic since 
exposure is highly variable, depending on frequencies and types of signals.147
In its 2005 Electromagnetic Fields Annual Update, the HCN discussed the 
available epidemiological studies on cancer incidence near radio and television 
transmitters.148 Several included childhood leukaemia. The HCN concluded that 
the overall picture emerging from these studies shows that there is insufficient 
evidence to establish an association between living in the immediate vicinity of a 
radio or television transmitter and increased risk of leukaemia or any other form 
of cancer.148
A more recent case-control study found no association between childhood 
leukaemias (and other early childhood cancers) and the estimated RF exposure 
from mobile telephone base stations of the mothers during pregnancy.149Physical environmental factors 67
Recent reviews of experimental studies indicate a low plausibility for a 
causal relation.150,151
Based on indications for an increased risk for glioma, a malignant type of 
brain cancer, associated with mobile phone use, in 2011 IARC has classified RF 
EMF as ‘possibly carcinogenic to humans’ (group 2B).152 Data on childhood 
leukaemia were not provided.
Evaluation
There is inadequate epidemiological evidence that pre- or postnatal exposure to 
RF EMF does increase the risk of childhood leukaemia, and the plausibility of a 
causal biological mechanism is low. The Committee therefore considers the 
existence of a causal relation between exposure to RF EMF and childhood 
leukaemia to be unknown.
Recommendations
Since the general trend is likely one of increasing exposures, more insight in 
actual exposures is recommended. Further research on the potential association 
between RF EMF and childhood leukaemia is not considered to be a high 
priority.
5.4 Diagnostic ultrasound scans during pregnancy
Ultrasound is a commonly used imaging modality during pregnancy, and is 
generally regarded as safe to the foetus.153 Current ultrasound technology, 
however, has a significantly higher output potential than the older machines used 
in most clinical studies, and the safety profile of the increasingly frequent use of 
Doppler, 3-dimensional (D) and 4-D ultrasound with modern machines is 
unknown. Since ultrasound is a form of energy, it has the potential to produce 
biological effects that may constitute a risk for health.154 Prenatal diagnostic 
ultrasound scans are increasingly used during pregnancy.153 In the Netherlands, a 
routine ultrasound scan is offered to all pregnant women in the first and the 
second trimester of the pregnancy, the latter having been added in 2006.155 In 
Belgium, three standard ultrasound scans are offered per pregnancy. Ultrasound 
exposure of the mother has also been investigated as a possible causal factor for 
childhood leukaemia.
Evidence
Information on the possible effects of ultrasound exposure in utero on the 
incidence of ALL or AML is not available, and the systematic analysis identified 
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risks were observed. A more recent systematic review carried out by the WHO 
concluded that ultrasound in pregnancy was not associated with childhood 
leukaemia nor with other adverse health effects.154 In a recent case-control study, 
logistic regression models which adjusted for maternal age and child's birth 
weight also showed no evidence of increased risk of childhood cancer due to in 
utero exposure to ultrasound scans.157 
Experimental evidence has shown that ultrasound is capable of inducing 
double strand breaks in DNA, but this only occurs only at higher energy levels 
than the ones used in diagnostics.158 
Evaluation
Considering the available diagnostic imaging techniques, ultrasound offers the 
best possibilities to reduce exposure to medical ionising radiation. According to 
the epidemiological evidence, exposure to diagnostic ultrasound during 
pregnancy appears to be safe. However, new experimental data indicates that 
DNA can be mechanically damaged, albeit at higher levels than used in 
diagnostic ultrasounds. 
The available epidemiological data does not support a potential causal 
relation between the current diagnostic ultrasound exposure and the risk of 
childhood leukaemia, neither does the scarce experimental data (only available at 
higher energy levels than used in diagnostics). Therefore, the Committee 
considers a causal relation between the limited exposures to routine diagnostic 
ultrasounds and childhood leukaemia unlikely. Ultrasound exposure can be 
assumed to rise, both in frequency and in level. Whether a causal relation may 
exist between more frequent and higher level exposures and childhood 
leukaemia is unknown.
Recommendations
Since ultrasound scans are offered to all pregnant women in the first and second 
trimester of pregnancy, exposure is very common. Since technical developments 
may be expected to result in higher exposure levels, possible adverse effects of 
more intensive or frequent ultrasound scans, e.g. following in vitro fertilisation 
(IVF), warrant further research, and the recommendation that ultrasound scans 
should not be offered without medical indication.Physical environmental factors 69
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6 Chemical environmental factors
In this chapter the role of chemical risk factors on the induction and development 
of childhood leukaemia is evaluated. These include pesticides, benzene, organic 
solvents other than benzene, arsenic in drinking water, parental tobacco smoking, 
parental marijuana smoking, parental alcohol consumption, maternal intake of 
cured meat, and other chemicals. 
6.1 Pesticides
‘Pesticides’ is a generic term used for a great number of chemical preparations. 
Over the last decades, several hundreds of pesticides have been marketed for 
agricultural or domestic use. They consist of biologically active ingredients 
commonly used to control unwanted organisms in agricultural and residential 
(indoor or outdoor) environments, and are grouped or classified according to the 
pests they control (i.e. insecticides, herbicides, fungicides, rodenticides), their 
application (plant protection products or biocides), their chemical structure 
(organic or inorganic), how/when they work (i.e. contact, systemic, residual, etc.) 
or their mode/site of action (i.e. inhibitors of acetyl CoA carboxylase, inhibitors 
of acetyl cholinesterase, etc.).
Pesticides are widely used: they protect agricultural crops against disease and 
infestation, they remove weeds from pavements, and they combat vermin in and 
around homes. They may, however, also be harmful to other than the target 
organisms. And they may have unwanted effects on human health. Some 
pesticides can cause short-term (acute) as well as long-term (chronic) adverse 
effects, including cancer. There are three main routes of exposure to pesticides: 
oral, dermal, and inhalation.
Pesticide exposure
Given their widespread use, pesticides are ubiquitously present in our 
environment and humans are inevitably exposed: the general population (adults 
and children) come into contact with the residues of pesticides in air, water and 
food, and occupational groups may be exposed at all stages of pesticide 
formulation, manufacturing, application or re-entry. The level, however, varies 
according to the patterns of exposure. Individuals who personally apply 
pesticides in agricultural, occupational or residential settings are likely to 
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through drinking water, air, dust and food is likely to result in low-level 
exposures.159
Exposure scenarios vary greatly among groups and across the world. Low 
amounts of pesticides (residues) can remain in or on a crop after harvesting or 
storage and make their ways into the food chain. That is why they are only 
allowed onto the market after an extensive safety assessment.160 In many 
countries, Belgium and the Netherlands included, accepted levels of residues in 
food are controlled by regulatory bodies. 
A recent study, based on the 2008 surveillance data of the Belgian Federal 
Agency for the Safety of the Food Chain, has demonstrated that for most of the 
pesticide residues in fruits and vegetables, the chronic exposure of the adult 
population is 100 times lower than the ‘acceptable daily intake’ (ADI)*. With 
regard to children, however, there are indications that for some pesticides** the 
ADI can be exceeded.161
Children can be exposed to pesticides from various sources: indirectly via 
parental (occupational) exposure, but also directly via residential exposure, e.g. 
from indoor use (biocides in homes, schools or other buildings), from outdoor 
use (garden, playing areas/public lands, agricultural application drift, overspray 
or off-gassing), through residues in food and drinking water, by handling pets 
treated or contaminated with biocides or other pesticides, or by other routes (e.g. 
through the use of insecticidal shampoos for lice infestation).162 Three critical 
time windows of exposure are relevant to the effects of pesticides in children: 
exposure of the parents prior to conception, exposure of the mother during 
pregnancy, and exposure of the child after birth. 
Pesticides have been particularly scrutinised as potential aetiological factors 
in childhood leukaemia.9,163-165 Discrepancies among epidemiological studies 
have made it especially important to conduct systematic reviews and meta-
analyses.166-170 In the following sections the Committee provides a brief 
overview of these reviews.
Epidemiological evidence on parental occupational exposure
Indirect exposure of children through occupational exposure to pesticides by 
adults in the reproductive age may substantially exceed the exposures from other 
sources.166
Systematic reviews, one included in the CCG Evidence Summary166 and one 
published later168, indicate increased risks for ALL, AML and childhood 
leukaemia in general following prenatal maternal occupational exposure to 
pesticides, although not reaching statistical significance for ALL in one 
review.168 The associations with paternal occupational exposure to pesticides 
* ADI: measure of the amount of a specific substance in food or drinking water that can be ingested on 
a daily basis over a lifetime without an appreciable health risk.
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before conception were weaker, and no significantly increased risks were 
observed for ALL, AML or childhood leukaemia in general. 
A third more recent meta-analysis observed different results, as paternal 
exposure was associated with a significantly increased risk of childhood 
leukaemia.170 However, these results have to be viewed with caution, since 
several overlapping datasets were included. Therefore, the results cannot be 
reasonably compared with those of the other meta-analyses*.
Epidemiological evidence on residential exposure
Residential pesticide use, defined as indoor or outdoor domestic use of 
pesticides, is associated with elevated exposure of children.167 Systematic 
reviews, one included in the CCG Evidence Summary and one published later, 
investigated residential pesticide exposure during the three critical time 
windows: preconception, pregnancy and childhood.167,169 Studies on the 
proximity to agricultural activities were not included in these meta-analyses. 
Significantly increased risks associated with exposure during pregnancy 
were observed for ALL in both reviews, and for AML in one review.169 During 
childhood no significantly increased risks for ALL and AML were found. 
However, both reviews did report statistically significant associations between 
childhood leukaemia in general and exposure during pregnancy, as well as during 
childhood.167,169 
A third more recent meta-analysis reported significantly increased risks for 
childhood leukaemia in general connected with parents’ use of pesticides in the 
home or garden.170 This is in agreement with the results of the two earlier 
systematic reviews. 
As in the previous section, however, the Committee considers that these 
results need to be viewed with caution, since several overlapping datasets were 
included and the results therefore cannot be reasonably compared with those of 
the other meta-analyses. 
One more systematic review investigated whether professional pesticide 
treatments (i.c. pest control) in or around the home before birth or during 
childhood increased the risk of childhood ALL.171 An increased risk of 
borderline statistical significance was observed when pesticide treatment was 
applied during pregnancy. The results for treatments carried out between birth 
and diagnosis were similar, and slightly lower. 
* Some methodological aspects of this meta-analysis are of questionable value: the authors have 
extracted several risk estimators (and variances) from each individual study, rather than one estimator 
per study, to compute the summary effects in the meta-analyses.163 This renders it impossible to 
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Other evidence
In 1991, IARC evaluated the carcinogenic risk to humans posed by occupational 
exposure during the spraying and application of insecticides, on the basis of the 
epidemiological and experimental studies.172 The volume also features separate 
monographs evaluating the carcinogenicity of 17 individual pesticides, including 
several that have been banned by industrialised countries, but that are still in use 
in the developing world. Although some of these pesticides have been applied for 
more than four decades, evaluations of carcinogenicity were hindered by the 
scarcity of well-designed epidemiological studies. 
The first and most extensive monograph was dedicated to an evaluation of 
data from various epidemiological studies suggesting an increased risk of cancer, 
most notably lung cancer, multiple myeloma and other tumours of B-cell origin 
in workers exposed to insecticides during their application. On the basis of this, 
IARC concluded that the spraying and application of non-arsenical insecticides 
entail exposures that are ‘probably carcinogenic to humans’. 
In the remaining monographs an evaluation was carried out of the 
carcinogenicity of aldicarb, atrazine, captafol, chlordane, DDT, deltamethrin, 
dichlorvos, fenvalerate, heptachlor, monuron, pentachlorophenol, permethrin, 
picloram, simazine, thiram, trifluralin, and ziram*. Of these, captafol, a fungicide 
used on plants for seed treatment and as a wood preservative, was classified as 
‘probably carcinogenic to humans’. Atrazine, chlordane, DDT, dichlorvos, 
heptachlor and pentachlorophenol were classified as ‘possibly carcinogenic to 
humans’ (see Annex F). The remaining pesticides could not be classified on the 
basis of available data. Among these are deltamethrin, picloram, thiram and 
ziram, which are still approved in EU countries.
More recently, several pesticides appeared to be able to change gene 
expression through a broad array of gene regulatory mechanisms, including 
regulation of gene translocation, DNA methylation or DNA repair.173
Causality considerations
As there is a lot of controversy and debate with regard to the role of pesticide 
exposure in childhood leukaemia, and the available information appeared to be 
not unequivocal, the Committee followed explicitly the well-established 
Bradford Hill considerations to evaluate, as objectively as possible, the available 
scientific evidence that pesticide exposure may cause childhood leukaemia (see 
also Annex E).14,15
Strength. Inherent to most environmental factors, the observed associations 
between pesticide exposure through parental occupational exposure or 
* Of these, aldicarb, atrazine, captafol, chlordane, DDT, dichlorvos, fenvalerate, heptachlor, monuron, 
pentachlorofenol, permethrin, simazine and trifluralin are no longer approved in EU countries.74 Childhood leukaemia and environmental factors
residential exposure and childhood leukaemia were mostly weak and only barely 
significant.
Consistency. Although all meta-analyses showed a tendency toward 
increased risk (except in the case of paternal occupational exposure and AML), 
discrepancies were observed in statistical significance. This might argue against 
a causal relationship. For childhood leukaemia in general, the statistically 
significant associations with pesticide exposure during pregnancy (via maternal 
occupational or residential exposure) observed in the different meta-analyses 
tends to support a causal relationship. It has to be stressed, however, that the 
individual studies included in the different meta-analyses are largely the same 
ones, and the consistency in the results is therefore not surprising.
Specificity. The ability to associate specific pesticide exposures with specific 
childhood cancers is limited by both the low prevalence of childhood cancer and 
the imprecise exposure assessment. The aetiology of childhood leukaemia is 
likely multifactorial, resulting from the effect of either genetic or environmental 
factors, and, probably, from their interaction. Conversely, pesticide exposure is 
not uniquely associated with childhood leukaemia.
Temporality. While it is obvious that, given a causal relationship, an exposure 
to a risk factor should occur before childhood leukaemia develops, it is not clear 
in which time window it would exert its causative action: prior to conception, 
during early, mid or late pregnancy or during childhood. However, maternal 
exposure to pesticides during pregnancy appears to be more consistently 
associated with childhood leukaemia than exposures during childhood.
Biological gradients. Many of the epidemiological studies did not attempt to 
assess cancer risks in response to increasing frequency or intensity of pesticide 
exposures. However, some authors tried to establish an exposure-response-like 
relationship between residential exposure to pesticides and childhood leukaemia 
in general.169 Although they showed that, in most cases, the risk of leukaemia is 
increased with frequency of use, these observations provide only weak additional 
support to the suspicion of a positive exposure-response relationship between 
pesticide exposure and childhood leukaemia.
Plausibility. Pesticides are biologically active molecules that may play some 
role in cancer aetiology. The US Environmental Protection Agency (EPA) and 
other national and international bodies have identified about 165 active 
ingredients of pesticides as known, probable or possible human carcinogens, 
many of which have been banned or restricted.174
Evaluation
Due to limitations in the available research, including questions regarding 
exposure assessment and exposure-response, the epidemiological evidence that 
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increased risk of childhood leukaemia in general is classified as limited. The 
most consistent evidence is for maternal exposures during pregnancy. 
In spite of the scarcity of specific data on ALL, the Committee still considers 
the evidence for this type of leukaemia to be limited, as it is by far the most 
common type of leukaemia in children and data for leukaemia in general are 
heavily weighted towards ALL. It would therefore be unrealistic to conclude 
differently for leukaemia in general and for ALL. 
The evidence regarding AML, on the other hand, is inadequate. The 
available studies are scarce, and some are of insufficient quality to allow for a 
robust conclusion on causality. In addition, the epidemiological evidence is 
based on data from case-control studies with, in most cases, poor characterisation 
of exposure. Chance, bias or confounding cannot be ruled out with reasonable 
confidence. Since several pesticides have been classified as known, possible or 
probable* human carcinogens**, causal relations with (past) exposures to 
(mixtures of) pesticides are moderately to highly plausible. 
Based on the available evidence, which is scarcer for ALL and AML than for 
childhood leukaemia in general, the Committee considers a causal relation 
between exposure to pesticides and childhood leukaemia in general and ALL 
possible to likely, and a causal relation between exposure to pesticides and AML 
uncertain to possible. The Committee does not rule out that past exposure to 
specific (classes of) pesticides might play a greater role in the development of 
childhood leukaemia than others.
Public health relevance
Population attributable fractions (PAF) have been calculated for maternal 
occupational exposures during pregnancy***, ranging from 1% (for all types) to 
4% (for ALL) and 5% (for AML). Residential exposures have been calculated to 
account for 17% (in the case of ALL), 25% (for all types), and 26% (for AML). 
This indicates that especially residential exposures are relevant, provided the 
relation with childhood leukaemia can be considered causal. 
Recommendations
The Committee recommends reducing parental, and particularly maternal, 
occupational exposure to pesticides. Also, it recommends the monitoring of 
pesticide exposures among occupationally exposed women, at least of 
* Probable carcinogen (US EPA classification) or ‘presumed’ carcinogen (EU classification).
** ‘Known’ and ‘presumed’ carcinogenic pesticides will no longer be approved in EU countries.
*** Personal communication Van Maele-Fabry 2011: For occupational exposure, the data from the 
systematic review of Wigle et al. were used for ALL and AML (based on 1213 cases and 674 
controls); for all types of leukaemia and for residential exposure, the data from the systematic review 
of Van Maele-Fabry et al. were used (based on 3386 controls).166,168,169 76 Childhood leukaemia and environmental factors
reproductive age, incorporating biomarkers of exposure whenever feasible. In 
general the Committee advocates preventive actions, including education and 
counselling, focused specifically on women of childbearing age, resulting in 
more risk awareness previous to intended conception. Furthermore, limiting the 
use of pesticides or biocides for residential purposes is recommended, in order to 
keep the exposure of pregnant women and young children as low as possible.
The possibility of simultaneous exposure to several pesticides with a 
common mechanism of toxicity and of simultaneous exposure to the same 
compounds from various sources, including food, merits systematic attention in 
the risk assessment of individual pesticides.160 Finally, the Committee 
recommends to include young children in risk assessments.
6.2 Benzene
Benzene is a frequently used organic solvent and a component of gasoline, 
ubiquitously present in the environment, although in general in relatively low 
concentrations. In epidemiological studies occupational exposure to benzene has 
been associated with adult AML.175 To a lesser extent associations have been 
found between environmental exposure situations and childhood leukaemia. 
Evidence
Evidence for an association between benzene exposure and childhood leukaemia 
is accumulating. Multiple epidemiological studies have shown an increase in 
childhood ALL, and particularly in AML, nearby air pollution sources emitting 
benzene, such as gas stations and traffic.176,177 However, the available reviews 
present different conclusions regarding environmental exposures.
IARC classifies benzene as ‘carcinogenic to humans’.178 This classification 
has been primarily based on the relation with adult AML found in occupational 
epidemiological studies. Although leukaemia in children (predominantly ALL) 
undoubtedly has some biological characteristics that differ from leukaemia 
occurring at a later age (predominantly AML), the pattern of ‘microdeletions’ of 
relevant genes in adult and adolescent leukaemia sufficiently resembles that in 
childhood leukaemia to suggest that, genetically speaking, adult, adolescent and 
childhood cases may be more similar than previously thought.179 
Benzene may be leukaemogenic through genotoxic, epigenetic and other 
gene-regulatory mechanisms. It induces chromosomal abnormalities, epigenetic 
modifications, including changes in DNA methylation of genes related to 
carcinogenesis, which lead to changes in gene expression. Moreover, benzene 
has been observed to cause haematotoxic effects and to activate cell-cycle-
regulating genes, resulting in compensatory formation of white blood cells.180
These haematotoxic properties of benzene are also suggestive of leukaemogenic 
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More recently gained mechanistic insights lend support to the potential 
associations between benzene exposure and childhood leukaemia.176 
Evaluation
The few available data from epidemiological studies on the relation between 
exposure to benzene and childhood leukaemia are not consistent, in part due to 
insufficient exposure data. However, the data on adult leukaemia do show 
consistent associations between occupational exposure to benzene and 
leukaemia, especially AML. Recently supporting mechanistic evidence has also 
become available. 
Overall, the Committee considers the epidemiological evidence for an 
association of exposure to benzene and childhood leukaemia to be limited, and 
the biological plausibility of causality to be high. The Committee therefore 
considers a causal relation between exposure to benzene and childhood 
leukaemia to be likely.
Recommendations
In order to obtain more solid evidence on the possible causal relation between 
exposure to benzene and childhood leukaemia, targeted monitoring studies 
should be performed in situations where exposure may occur. In the meantime, 
the available evidence warrants taking measures to limit or prevent exposure of 
children and pregnant women to benzene. In particular counseling previous to 
intended conception may improve risk awareness of traffic exposures and other 
sources of benzene exposure of pregnant women and children.
6.3 Organic solvents other than benzene
Organic solvents are commonly used, for instance in gasoline or indoors as a 
paint thinner or in chipped wood (i.c. formaldehyde). This is a very broad 
category. For most solvents no information on possible effects on childhood 
leukaemia is available, therefore only some examples can be discussed.
Evidence
For a number of specific solvents epidemiological evidence is available that they 
might contribute to the risk of childhood leukaemia.181-183 In a study among 
children with ALL, 15.2% showed specific genetic mutations that were related to 
maternal exposure to solvents.184 However, a more recent review concluded that 
there is no consistent support for the claim that parental exposure to solvents and 
petroleum-based hydrocarbons is a causative factor in the development of 
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For several other substances (including styrene and formaldehyde), only 
associations have been reported between adult exposures and adult 
leukaemia.185-188
In 1989, IARC classified diesel engine exhaust as ‘probably carcinogenic to 
humans’ and gasoline engine exhaust as ‘possibly carcinogenic to humans’.178
Petroleum solvents were considered as ‘not classifiable as to their 
carcinogenicity to humans’. Occupational exposure as a painter was classified as 
‘carcinogenic to humans’. However, occupational exposure in paint manufacture 
was considered as ‘not classifiable as to its carcinogenicity to humans’.
Formaldehyde is an established human carcinogen178, known to induce 
chromosomal abnormalities in blood cells.189 Styrene is classified by IARC as a 
‘possibly carcinogenic to humans’178 and is associated in many epidemiological 
studies with cancers of the blood-forming organs and the lymphoid system in 
adults.190 These substances might therefore potentially contribute to an increased 
risk of childhood leukaemia.
Evaluation
The Committee considers the available evidence from epidemiological studies 
inadequate as a basis for any conclusion on a relation between exposure to 
organic solvents other than benzene and childhood leukaemia. Without 
experimental data, it therefore considers a causal relation between most organic 
solvents and childhood leukaemia as unknown.
Since specific organic solvents such as styrene and formaldehyde have been 
classified respectively as ‘possibly and established carcinogenic’, the Committee 
considers the plausibility of a causal relation with childhood leukaemia for these 
solvents respectively as moderate and high. Therefore, the Committee considers 
a causal relation with exposure to specific organic solvents such as styrene and 
formaldehyde respectively as uncertain and possible.
Based on IARC evaluations, the Committee considers a relation with 
exposure to engine exhausts as moderately to highly plausible and occupational 
exposure to paints as highly plausible. Therefore she considers a causal relation 
with childhood leukaemia for engine exhausts uncertain to possible and for 
occupational exposure to paints as possible.
Recommendations
The application of volatile organic compounds with carcinogenic properties, 
such as styrene and formaldehyde, in materials commonly encountered in the 
living environment should be avoided. Reducing exposures to solvents, for 
instance during painting indoors, might also be beneficial for the prevention of 
other adverse health effects. In view of the scarcity of adequate information, 
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relation between commonly encountered organic solvents and childhood 
leukaemia. 
6.4 Arsenic in drinking water
Arsenic is widely occurring both naturally and as a result of human activity. Food 
is the main source of exposure for the general population in Europe.191 Inorganic 
arsenic is produced primarily as a by-product from metal smelting processes.192
Up to 70% of global arsenic production is used in the industrial preservation of 
wood, as chromated copper arsenate (CCA).
Arsenic combines with oxygen, chlorine, and sulphur to form inorganic 
arsenic compounds, which are more toxic. Inorganic arsenic compounds have 
been found as contaminants of drinking water worldwide. They enter drinking 
water supplies from natural deposits in the earth or from agricultural and 
industrial practices. Arsenic has been found to cross the placenta, and can cause 
foetal toxicity.193
The Joint FAO/WHO Food Standards Programme Codex Committee on 
contaminants in food has noted that drinking water is a major contributor to total 
inorganic arsenic dietary exposures and, depending on the concentration, can 
also be an important source of arsenic in food, through food preparation and 
possibly irrigation of crops.194 For certain regions in the world, where 
concentrations of inorganic arsenic in drinking water are above the WHO 
guideline value of 10 μg/l, the FAO/WHO Committee has remarked that there is 
a possibility that adverse effects could occur. The provisional guideline value for 
a ‘safe limit’ for arsenic in drinking water has been adopted as a national 
standard worldwide, including the European Union.
Arsenic has been shown to cause cancer in human beings (e.g. lung, skin, 
bladder), but few studies have been conducted to assess whether arsenic 
exposure is also a risk factor for childhood cancers.195
Evidence
In two reviews, including one identified in the CCG Evidence Summary, no 
statistically significant increased risks for childhood ALL were observed in 
relation to high levels of arsenic in drinking water.195,196 
IARC classifies arsenic and inorganic arsenic compounds as ‘carcinogenic to 
humans’.178
Evaluation
The Committee concludes that there is inadequate epidemiological evidence that 
exposure to inorganic arsenic compounds in drinking water is associated with an 
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compounds have been classified as carcinogenic, the biological plausibility for 
causality is considered high, however. As a consequence, the Committee 
considers a causal relation between exposure to inorganic arsenic compounds in 
drinking water and childhood leukaemia possible.
Public health relevance 
In view of the ubiquitous potential of exposure to inorganic arsenic compounds 
by ingestion of drinking water, the relevance to public health is obvious. Even 
when the concentrations remain below the levels recommended by WHO, the 
resulting health problems are not negligible.197 However, due to a lack of data the 
effect on childhood leukaemia cannot be estimated. 
Recommendations
The Panel on Contaminants in the Food Chain (CONTAM Panel) has 
recommended that exposure to inorganic arsenic should be reduced.191 The 
Committee endorses this recommendation. If this general recommendation is 
followed, there is no need for further studies on a possible relation between 
exposure to arsenic and childhood leukaemia.
6.5 Parental tobacco smoking
Another chemical factor that may enhance the risk of childhood leukaemia is 
parental tobacco smoking. The effects of passive smoke on cancers other than 
lung cancer are, however, still a matter of discussion.198
Evidence
A meta-analysis identified in the CCG Evidence Summary studying the 
association between the amount of parental tobacco smoking and childhood 
cancers showed inconsistent results with respect to risks for ALL and AML.198 A 
more recent meta-analysis observed an increased cancer risk for any paternal 
smoking around the time of the child’s conception and for smoking more than 20 
cigarettes per day around that time.199 As most studies of maternal smoking 
during pregnancy have reported no increased risks for the occurrence of 
childhood cancers, a meta-analysis for maternal smoking was not conducted.
IARC has classified (second-hand) tobacco smoke as ‘carcinogenic to 
humans’.178 Chemical environmental factors 81
Evaluation
The Committee concludes that there is limited evidence that paternal smoking 
increases the risk of childhood leukaemia. Since there is ample evidence that 
tobacco smoke is carcinogenic, the Committee considers the biological 
plausibility high and a causal relation between paternal tobacco smoking and 
childhood leukaemia likely. For maternal smoking the epidemiological evidence 
is inadequate, so a causal relation in that case is possible. Causal relations with 
ALL and AML separately are uncertain.
Recommendations
Since parental smoking increases the risk of many disorders in embryos, foetuses 
and children (abortion, preterm birth, intra uterine growth retardation, congenital 
malformations, sudden infant death, asthma, allergy)200, parents should be 
urgently advised to stop or avoid smoking before conceiving a child. It is 
advisable to do so at least three months before intended conception, and maintain 
this during and after pregnancy. 
6.6 Parental marijuana smoking
Marijuana smoke contains several of the same carcinogens and co-carcinogens 
as the tar from tobacco, raising concerns that smoking marijuana may be a risk 
factor for tobacco-related cancers and, possibly, for childhood leukaemia.201 
Evidence
In a review included in the CCG Evidence Summary, the association between the 
frequency, duration, amount, mode and period of marijuana use (ever, 
preconceptionally, during pregnancy or current) and cancer risk was looked into. 
In one study maternal use of marijuana during pregnancy or in the year before 
pregnancy was found to be associated with an increased risk for AML.201
However, no other studies corroborated this finding.
Evaluation
The available epidemiological data provide inadequate evidence that parental 
use of marijuana during or in the year preceding pregnancy increases the risk of 
childhood AML. In view of the known toxic properties of cannabinol 
derivatives, however, the Committee considers a causal mechanism moderately
plausible. Overall, the Committee considers the existence of a causal relation 
between parental marijuana smoking and AML uncertain, and a causal relation 
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Recommendations
Targeted epidemiological studies would be helpful in obtaining more 
information. Considering the toxic properties of cannabinol and the parallels 
with tobacco smoking, parents should be urgently advised to stop or avoid using 
cannabis at least three months before intending to conceive a child, to be 
continued during pregnancy and childhood.
6.7 Parental alcohol consumption
Given that the metabolites of alcohol are carcinogenic and that leukaemia can 
arise prenatally, parental alcohol consumption was studied as a potential risk 
factor for the development of childhood leukaemia in the offspring. 
Evidence
A review identified in the CCG Evidence Summary studied the effect of amount, 
type and period of parental alcohol consumption on the incidence of childhood 
ALL and AML.202 Maternal alcohol consumption one year before pregnancy 
showed a non-significantly higher risk for ALL in one individual study. For 
maternal alcohol consumption one month prior to pregnancy a significant higher 
risk for AML was found in one study, while for paternal alcohol consumption in 
several studies non-significantly higher risks for both ALL and AML were 
found.
On the basis of available in vitro studies, animal experiments and studies in 
non-pregnant women the possibility cannot be ruled out that exposure to even 
very low amounts of ethanol may increase the risk of cancer.20
IARC classifies the consumption of alcoholic beverages as ‘carcinogenic to 
humans’.178
Evaluation
Although there are indications that parental alcohol use preceding conception 
and maternal alcohol use during pregnancy may increase the risk of a child 
developing leukaemia, the Committee concludes that there is inadequate
epidemiological evidence for an association of this kind. Since IARC has 
classified the consumption of alcoholic beverages as ‘carcinogenic to humans’, 
the Committee considers the biological plausibility as high. Overall, the 
Committee considers a causal relation between parental alcohol consumption 
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Recommendations
Since alcohol consumption is considered ‘carcinogenic to humans’, and parental 
(mainly maternal) alcohol use prior to conception and during pregnancy 
increases the risk of other disorders in embryos, foetuses and children (reduced 
fertility, miscarriage, foetal death, intra-uterine death, premature birth, congenital 
malformations or adverse effects on the child’s psychomotor development), the 
Committee recommends that parents-to-be abstain from alcohol consumption 
prior to intended conception, and mothers also during pregnancy.203,204   
6.8 Maternal cured meat intake
Since transplacental exposure to N-nitroso compounds have been shown to 
produce tumors in laboratory animals and these compounds are sometimes found 
in cured meat or may be formed endogenously, consumption of cured meat 
during pregnancy was studied as a potential risk factor for the development of 
cancers in the offspring.205  
Evidence
Three of the epidemiological studies identified in a systematic review of 
childhood leukaemia in general, have studied the association between the intake 
of individual cured meats, such as luncheon meat, ham, bacon, sausages or hot 
dogs and childhood leukaemias.205 Both higher and lower risks were found, but 
they were either non-significant or without the significance level mentioned.
Experimental investigations have shown that transplacental exposure to N-
nitroso compounds, which are sometimes found in (nitrite-) cured meats, can 
produce tumors in laboratory animals.205 IARC classifies the consumption of 
nitrite under conditions that result in endogenous nitrosation (high acidity 
environment of the stomach) as ‘probably carcinogenic to humans’.178
Evaluation
There is inadequate evidence that consumption of cured meat is a potential cause 
of childhood leukaemia.205 The experimental evidence indicates a moderate
plausibility of causality. Overall, the Committee considers a causal relation 
between consumption of cured meat during pregnancy and childhood leukaemia 
to be uncertain. 
Recommendations
Since IARC classifies the consumption of nitrite as ‘probably carcinogenic to 
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recommends targeted studies into a relation between cured meat ingestion during 
pregnancy and childhood leukaemia. The Committee also recommends limiting 
the intake of nitrite-cured meat (e.g. ham, bacon and sausages) by pregnant 
women. 
6.9 Other chemicals
There are many chemicals for which limited or no information on health risks is 
available. Some of these may contribute to the risk of childhood leukaemia, such 
as persistent organic pollutants (POPs).206 The 4th WHO-coordinated survey of 
human milk for POPs has indicated that most organochlorinated pesticides 
banned 25-30 years ago were below or around detection limits in Belgian human 
milk samples, although DDE was still found at low levels in all samples.207 Over 
the last five years the levels of marker PCBs* and PCDD/Fs** in Belgian human 
milk decreased by 58% and 39% respectively. 
Evidence
Parental occupational exposure to different chemicals and industrial dusts or 
fumes was assessed in three German case-control studies that were conducted 
from 1992-1997. Maternal exposure to paints or lacquers before conception and 
during the pregnancy was shown to be related to an increased risk of childhood 
ALL.183 
In a large case-control study in the US an association between self-reported 
paternal exposure to plastic materials during the preconception period and ALL 
was found.182 Also maternal exposure to plastic materials during the postnatal 
period were related to an increased risk of childhood ALL. An earlier case-
control study in the US investigated occupational exposures of parents of 204 
children (younger than 18 years) with acute non-lymphoid leukaemia. The most 
consistent finding was an association with pesticide exposure (see 6.1).181 Other 
occupational exposures were also reported significantly more often: paternal 
exposure to solvents, petroleum products, plastics or lead, and maternal exposure 
to paints and pigments, metal dusts and sawdust. 
In a nationwide case-control study in the Netherlands mothers of children 
with ALL reported a greater occupational exposure to chemicals (paint, 
petroleum products and unspecified chemicals) during pregnancy than mothers 
of controls.208
Among 837 children with ALL studied by the Childrens Cancer Study Group 
in the United States, 15.2% showed ras mutations.184 Specific ras mutations in 
the leukaemic cells were found to be associated with parental exposure to certain 
* PCBs: polychlorinated biphenyls.
** PCDD: polychlorinated dibenzo-p-dioxin; PCDF: polychlorinated dibenzofuran.Chemical environmental factors 85
medications, solvents, plastic materials, oil, coal products and other 
hydrocarbons. However, the risk of childhood leukaemia is modified by genetic 
characteristics affecting the metabolic activation or inactivation of exogenous 
chemicals. The risk for ALL increased threefold when three susceptibility 
genotypes occurred in the same children.209 This may suggest a causal relation 
between environmental exposures, specific ras mutations and ALL.
PCBs, which were classified as ‘probable human carcinogens’ by IARC in 
1987178 and which cause perturbations of the immune system, may represent a 
previously unrecognised risk factor for childhood leukaemia.210 In a case-control 
study in the USA, the highest levels of PCBs in carpet dust were associated with 
a three times higher risk of ALL.
Other substances that could potentially contribute to an increased risk of 
childhood leukaemia include specific phthalates (plasticisers); di(2-
ethylhexyl)phthalate is classified by IARC as a ‘possible human carcinogen.178
Evaluation
Epidemiological and biological data provide, respectively, limited and moderate 
to high evidence that specific (classes of) reactive (mutagenic or receptor-
binding) chemical agents found in the environment might, either alone or in 
combination with other factors, be contributing to childhood leukaemia. The 
Committee considers a causal relation for PCBs likely, for plasticisers possible
and for other chemicals unknown.
Public health relevance
Children that carry genetic polymorphisms which result in a comparative 
inability to process chemicals to which they are environmentally exposed, show 
a higher incidence of leukaemia.207 This indicates that these chemicals play an 
important role in the causation of leukaemia and that a segment of the population 
is at increased risk of leukaemia from these chemicals. This might explain a 
sizeable fraction of childhood leukaemia.211 However, specific information is not 
available.
Recommendations
Many chemicals may, either alone or in combination with other factors, 
contribute to the induction or development of childhood leukaemia. This requires 
an integrated approach. Since many different mutagenic or receptor-binding 
agents may be involved in the development of leukaemia, it seems desirable and 
reasonable to complement the traditional anti-microbial hygiene with ‘physical-
chemical hygiene’, limiting environmental exposures to possibly harmful agents 
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Furthermore, targeted epidemiological studies should be performed on agents 
associated with an increase in chromosomal abnormalities or DNA abnormalities 
(gene mutations) in human blood cells, as these agents have access to and are 
active in human haematopoietic tissues. These studies should not only target 
pesticides and organic solvents, but also other potentially reactive or genotoxic 
chemicals, such as polychlorinated biphenyls (PCBs) and phthalates 
(plasticisers).Chemical environmental factors 87
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7 Biological and other factors
This chapter explores the available evidence on the role of a number of other 
environmental factors on the occurrence of childhood leukaemia: infectious 
agents and immune reactions, maternal folate and vitamin supplementation, birth 
weight and socio-economic status. Some of these may have a protective effect. 
7.1 Infections and immune reactions
The relationships between various forms of immunological stimulation and the 
occurrence of childhood cancer are diverse and complex. In some cases a 
protective effect may be involved. In the following sections the Committee 
discusses the available scientific evidence regarding four groups of indicators for 
infections and immune reactions which have been identified as possible 
influences on childhood leukaemia: infectious exposures, early social contacts, 
allergies and breast-feeding. 
These possible associations may also shed light on an underlying mechanism.
In this regard, Greaves has proposed a general ‘delayed-infection’ hypothesis for 
childhood leukaemia36, in which the absence or diminution of infections early in 
life is stated to predispose the immune system to abnormal responses 
(‘inadequate priming’) when exposure to common infectious agents occurs at a 
later stage in life. A deregulated immune response to infection could then result 
in a potent inflammatory response. 
Postnatal malignant progression of prenatally initiated preleukaemic clones 
may also play a role in the risk of ALL, particularly common B-cell precursor 
ALL (cALL), the most common type of ALL. In other words, children who face 
a narrower range of antigens in early childhood may be, according to Greaves, 
more susceptible to leukaemogenesis in their maturing B-cell compartment.
7.1.1 Infectious exposures
There are two hypotheses concerning the role of infections in the aetiology of 
childhood leukaemia, each relating to a specific time of exposure:212  
• Absence or diminution of infections early in life, later followed by exposure 
to common infections (Greaves‘ hypothesis).
• Unusual infectious exposures, due to unusual ‘population mixing’ (Kinlen’s 
hypothesis).Biological and other factors 89
Evidence
In a review identified in the CCG Evidence Summary, different infectious 
exposures were shown to be associated with, on the one hand, direct indicators of 
exposure to infectious agents, and to be associated with, on the other hand, 
indirect (‘proxy’) indicators, such as vaccinations, breast-feeding, early day-care 
attendance and unusual ‘population mixing’.212 Where maternal infections 
during pregnancy are concerned, several studies have shown significantly or 
non-significantly higher risks for ALL. In the case of childhood infections, 
vaccinations and ‘individual social mixing’ (birth order), inconsistent results (i.e. 
both significantly higher and lower risks in identical settings and groups) were 
found. One study identified a statistically significant association between 
paternal occupational contact levels (i.e. the number of social contacts with the 
father whilst at work) and a higher risk for ALL.
For childhood leukaemia in general two individual studies showed 
inconsistent results with respect to a relation between paternal occupational 
contact levels and childhood leukaemia.213 Also for maternal infections, 
childhood infections, different vaccinations and birth order, inconsistent results 
were found. 
According to the ‘population mixing’ hypothesis of Kinlen, large increases or 
shifts in population enhance the opportunity to infect members of the resident 
population with infectious agents for which the community’s children have 
developed limited immunity.214 Kinlen has suggested that an epidemic of an 
underlying infection, to which childhood leukaemia may be a rare response, is 
promoted by marked population mixing in rural areas, where the prevalence of 
susceptible individuals is higher than average. 
Although the working mechanisms still need to be determined, a possible 
aetiological mechanism may be found in an abnormal immune response to 
common infections.36 This idea is supported by several discoveries: the 
retrovirus human T-cell lymphotropic virus 1 (HTLV1) is a causative factor for 
adult T-cell leukaemia and lymphoma; leukaemia in domestic cattle, cats and 
chickens is viral in origin; and Epstein-Barr virus is the causative agent in some 
lymphomas. Evidence from the mechanisms in other haematological cancers also 
supports this view.
Evaluation
The epidemiological evidence shows inconsistent results, and does not 
sufficiently support the hypotheses of Greaves and Kinlen to draw any 
conclusions as to their accuracy. The Committee therefore concludes that there is 
inadequate evidence that (responses to) different infectious exposures are 
associated with an increased risk of childhood leukaemia. One of the reasons for 
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infections and the immunological response are associated with multifactorial 
determinants.36 In addition, the Committee does not rule out that other than 
infectious environmental factors may play a role in explaining the observed 
association with population mixing. Large increases in a population (i.e. forming 
of ‘new towns’) might, for instance, also be associated with exposures to 
solvents in new buildings.
Because of the delayed-infection hypothesis of Greaves, the Committee 
considers the biological plausibility as moderate. The Committee therefore 
considers a causal relation between different infectious exposures and the 
incidence of ALL and childhood leukaemia in general uncertain, and considers 
the existence of a relation between infectious exposures and AML unknown. It 
may be possible that childhood exposures to common infections offer some 
protection against childhood leukaemia, specifically against ALL. Parental or 
childhood exposures to specific infectious agents (e.g. Epstein-Barr virus) may, 
however, increase the risk.
Recommendations
Since there is a lack of adequate data on a possible relation between infectious 
exposures and childhood leukaemia, more research in this area is warranted. It 
would be especially useful if, in addition to infectious agents, other 
environmental determinants of population mixing would be investigated.
7.1.2 Early social contacts
A rare response to common infections acquired by personal contact with infected 
individuals may be another relevant environmental factor in developing 
childhood leukaemia.215 This has been studied by looking into a possible 
association between day-care attendance and other early social contacts and the 
risk of childhood ALL, with specific attention paid to early-life exposure to 
infections and any protection this may provide against ALL. 
Evidence
In a review in the CCG Evidence Summary, the association between duration and 
timing of day-care attendance early in life (less than two years of age) and 
childhood ALL was investigated.215 This exposure measure served as an 
indicator for the increased likelihood of early exposure to infections. A pooled 
analysis of the identified data showed a significantly lower risk for common-
ALL*.
* Most frequent type of ALL: common B-cell precursor ALL (cALL).Biological and other factors 91
Evaluation
The epidemiological data provide sufficient evidence to suggest a protective 
association between early social contacts and the risk of ALL.215 Because of the 
‘delayed-infection’ hypothesis of Greaves, the Committee considers the 
biological plausibility as moderate. A protective effect of early social contacts in 
the case of ALL is therefore considered likely. In the case of AML it is unknown
whether such an effect occurs.
Public health relevance
No information is available on population attributable fractions. However, in 
view of the widespread nature of early social contacts, the Committee considers 
their potential protective effect to be very important. 
Recommendations
The Committee considers further research into the possible protective effects of 
early social contacts not of high priority. The Committee does however 
recommend to stimulate early social contacts between young children. This will 
also be beneficial for reasons other than reducing the risk of childhood 
leukaemia.
7.1.3 Allergies
Higher incidences of both childhood leukaemia and allergic diseases are found in 
western industrialised countries, as compared to developing countries.216
Worldwide incidence data indicate a significant correspondence between rates of 
childhood allergies and ALL, suggesting there may well be shared infectious or 
immunological risk factors.36 A decline in exposure to infections in early 
childhood might play a role in the aetiology and increase of both.
Evidence
In a systematic review identified in the CCG Evidence Summary, pooled 
analyses showed a significantly lower risk for ALL in persons with hay fever, 
eczema and overall allergy.216 
Evaluation
In spite of the above mentioned correspondence between childhood allergies and 
ALL in ‘ecological’ studies, from case-control studies, there is sufficient
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ALL.216 However, the Committee considers the biological plausibility of a causal 
relation between allergy and childhood leukaemia as low. The Committee 
therefore considers a protective effect of allergy (i.c. an allergic constitution) for 
ALL possible and for AML unknown.
Public health relevance
Despite the frequent occurrence of allergies in the population*, there is no 
information available to derive population attributable fractions.
Recommendations
The Committee sees no reason to give priority to further studies in this area.
7.1.4 Breast-feeding
It has been suggested that breast milk may play a role in the prevention of certain 
childhood cancers.217
Evidence
In the systematic review retrieved in the CCG Evidence Summary, breast-
feeding was associated with a significantly lower risk for ALL and AML.217 
Given the multiple immunological effects of breast-feeding in offspring, 
Greaves has considered this relation to be biologically plausible.218
Evaluation
There is sufficient evidence that breast-feeding is inversely associated with the 
development of childhood leukaemia. The Committee considers this to be 
moderately biologically plausible.218 The Committee therefore considers an 
inverse causal relation between breast-feeding and AML and ALL likely.
Recommendations
Since the Committee has concluded that a protective effect of breast-feeding is 
likely, and bearing in mind that breast-feeding has many other benefits, the 
Committee supports the recommendation made by the Netherlands Nutrition 
Centre, which is in turn based on the recommendations by the WHO, that, 
whenever feasible, infants should be exclusively breast-fed up to the age of 
approximately six months.219,220
* In the Netherlands, at least one in four children (12-14 years) reported allergic disorders.200Biological and other factors 93
7.1.5 Overall conclusion and recommendations
Whether other forms of immunological stimulation have the same protective 
effect as early social contacts, allergies and breast-feeding is not clear.215 The 
observed complexity certainly reflects the complexity of the stimulating and 
inhibiting influences of different immunological stimuli on the proliferation of 
the various cell types in haematological and immunological tissues. Because of 
the unknown interactions of infectious diseases, allergies and social contacts, the 
Committee concludes that there is limited evidence that infections and immune 
reactions are associated with the risk of childhood leukaemia. 
The Committee therefore considers a protective effect of exposure to 
common childhood infections and immune reactions regarding childhood 
leukaemia, and specifically regarding ALL, to be possible. Parental or childhood 
exposures to specific infectious agents (e.g. Epstein-Barr virus) may, however, 
increase the risk of childhood leukaemia.
The Committee concludes that not enough knowledge currently exists to 
recommend measures to prevent or stimulate exposure to infections or other 
immune reactions. An exception is made in the case of breast-feeding, since a 
recommendation in this regard is in line with existing advice to mothers. To 
further understand the role of infections or other immune reactions, more 
research would be necessary, for instance to explain space-time clustering of the 
incidence of childhood leukaemia in different populations.
7.2 Maternal folate and vitamin supplementation
Given the hypothesis that deficiencies in vitamins and some other micronutrients 
might increase the risk of cancer, and that leukaemia can arise prenatally, 
maternal folate and vitamin supplementation were studied as potential protective 
factors in the development of childhood leukaemia in the offspring.221 
Evidence
A review discussed in the CCG Evidence Summary studied the association 
between maternal use (and dose) of folic acid and other vitamin supplements 
before and during pregnancy, and the risk of ALL.221 In one study, a non-
significantly higher risk for ALL was observed in relation to folate 
supplementation before pregnancy. Pooled analyses showed non-significant 
results in the case of vitamin supplementation before pregnancy. For vitamin 
supplementation during pregnancy, however, a significantly lower risk for ALL 
was observed. Combinations of vitamins and folate did not reveal any 
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A protective effect of maternal folate supplementation during pregnancy 
against the occurrence of childhood leukaemia is biologically plausible, given its 
dual roles in methylation and the synthesis and repair of DNA.221
Evaluation
There is limited evidence that extra vitamin supplementation during pregnancy 
protects against ALL.221 However, the Committee found no evidence to consider 
this plausible and therefore considers a causal relation between vitamin 
supplementation during pregnancy and a decrease in ALL uncertain. Although 
the Committee considers a causal relation with folate intake as moderately
plausible, there is inadequate evidence from epidemiological studies that the 
intake of folate before or during pregnancy has a protective effect. So, whether a 
protective relation with folate supplementation exists is also uncertain. Based on 
the CCG Evidence Summary a causal relation with AML is unknown.
Recommendations
More research is required to obtain insight in the possible protective effect of 
vitamin supplementation during pregnancy on the risk of childhood leukaemia, 
in particular ALL. For other reasons than reducing the risk of childhood 
leukaemia, and since it is relatively easy to accomplish, folate supplementation 
should be promoted from four weeks before intended conception until eight 
weeks after conception.
7.3 Birth weight
A growing body of evidence suggests that childhood leukaemia may be initiated 
in utero when lymphoid and myeloid cells are not fully differentiated and are 
particularly susceptible to malignant transformation.222 Likewise, stem cells that 
give rise to the myeloid cell line may also be susceptible to circulating growth 
factors and hormones. These then act to increase the size of the stem cell pool, 
which in turn increases the total number of replicating cells now at risk for 
conversion into tumour cells. This subsequently may increase the risk of 
leukaemia. Since one factor related to the size of the stem cell pool is birth 
weight, this has been postulated as a risk factor for childhood leukaemia. 
However, birth weight has also been associated with other factors, some of which 
have been discussed before, e.g. smoking
Evidence
In the relevant review identified in the CCG Evidence Summary, a high birth 
weight was associated with a higher risk of ALL and AML, and a low birth Biological and other factors 95
weight with a higher risk of AML.222 Furthermore, for each kilogram increase in 
birth weight a higher risk for ALL was found. 
Evaluation
There is limited evidence that birth weight, affecting many physiological 
parameters, is associated with the risk of ALL (higher birth weight) and AML 
(higher and lower birth weight).222 The Committee considers the biological 
plausibility of a relation between a high birth weight and childhood leukaemia to 
be moderate. The plausibility that a relation with low birth weight exists is 
considered low. The Committee therefore considers a causal relation between a 
high birth weight and ALL or AML possible, and one between a low birth 
weight and AML uncertain and for ALL unknown.
Recommendations
In view of the benefits for many other aspects of health, a normal birth weight 
should be aimed for during pregnancy.
7.4 Socio-economic status
A long-held view links higher socio-economic status (SES) to higher rates of 
childhood leukaemia.223 Some recent studies, however, showed associations in 
the opposite direction.
Evidence
In a review identified in the CCG Evidence Summary, associations were studied 
between childhood ALL and AML and socio-economic circumstances.223 Family 
income and mother’s education showed inconsistent associations with ALL, with 
significantly higher AML rates, however, being found when family income was 
lower. In the case of paternal education, (non-)significantly higher ALL rates 
were associated with higher SES, while (non-)significantly higher AML rates 
once again showed an association with lower SES. One study, however, found 
significantly higher ALL rates to be related to ‘ecological’ SES measures at an 
aggregated or population level, i.c. higher education and occupational class. For 
childhood leukaemia in general, inconsistent associations were found for family 
income, parental education, father’s occupational class and household density.223
The authors of the original review concluded that case-control studies 
conducted in North America since 1980 have consistently reported inverse 
(negative) associations of childhood leukaemia with individual measures of 
family income, mother's education and father's education.223 In contrast, the 96 Childhood leukaemia and environmental factors
incidence of childhood leukaemia has consistently shown to be lower when 
father's occupational class is identified as low. 
Evaluation
The systematic analyses provide inconsistent evidence, showing both positive 
and negative associations of childhood leukaemia with indicators of SES. 
However, SES might only be a proxy for other factors that might explain the 
(indirect) relations. Based on these results, the Committee considers there to be 
inadequate epidemiological evidence for such associations. The Committee also 
considers the biological plausibility that a causal relation exists to be low. 
According to the Committee, the existence of a causal relation between SES and 
childhood leukaemia is therefore unknown.Biological and other factors 97
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8 Conclusion
The main objective in this report has been to evaluate the existing scientific 
evidence on possible relations between environmental factors and the occurrence 
of childhood leukaemia, and to recommend balanced measures to reduce risks 
when sufficient knowledge is available or uncertainties exist. In this final 
chapter, the Committee gives an overview of its conclusions and 
recommendations.
8.1 Conclusions on possible associations
Given that leukaemia is the most common malignancy in children, and observing 
the increase that has occurred in the last decade of the 20th century, there is every 
reason to look for ways to reduce environmental risks, although this trend now 
seems to have stopped and has maybe even been reversed. It needs to be noted, 
however, that a certain level of incidence of childhood leukaemia is inevitable, 
since genetic susceptibilities, naturally occurring exposures and man-made 
factors all play a role. Separating these influences to arrive at a baseline or 
‘natural’ occurrence of childhood leukaemia is impossible, since the 
development of leukaemia is a multifactorial process, depending on multiple 
consecutive events, and with simultaneous exposure to multiple factors. 
Complicated interplay of factors
The most important conclusions therefore are that (a) the majority of leukaemia 
cases cannot be explained; (b) only a small fraction of leukaemia cases might be 
prevented. Consequently, suggesting a full range of measures aiming at a 
baseline incidence is not possible. Where sufficient evidence is available for 
associations with individual factors and uncertainties exist regarding the 
complex interplay of risk factors, the precautionary principle can be used as a 
guideline. The uncertainties are due to our rudimentary knowledge about the 
multistep process that leads to the disease and about the way environmental 
factors, such as exposure to pesticides or other chemicals, affects this process. 
Knowledge about the role of concurrent or subsequent exposures and about 
critical pre- and postnatal periods of susceptibility is lacking or in varying 
degrees deficient.Conclusion 99
Likelihood of causality per factor
Arriving at conclusions on the role of separate causal relations has not proved to 
be easy. Most possible relations under consideration in this report could not be 
sufficiently established, given the available epidemiological and experimental 
evidence. 
In the following two tables the Committee summarises the findings, 
indicating for each factor to which extent the available evidence supports the 
likelihood of an association with childhood leukaemia and what measures and 
research are proposed. Table 6 contains the conclusions on possible risk factors, 
whereas Table 7 summarises the findings on factors with a possibly protective 
influence. Whenever a distinction could be made between ALL and AML this is 
indicated. In all other cases the Committee refers to ‘childhood leukaemia’. 
For most risk factors it has not been possible to calculate which percentage of 
leukaemias they cause. In a few cases, the Committee was able to provide rough 
estimates of ‘population attributable risks’ (PAFs), ranging from less than 1% for 
exposure to magnetic fields from overhead power lines up to 15-20% for 
exposure to naturally occurring ionising radiation. Since these numbers are very 
uncertain, they are not provided in the table.
8.2 Recommended measures
Which measures could be taken to reduce the impact of environmental factors on 
childhood leukaemia, or to utilise protective influences? Since many different 
mutagenic or receptor-binding agents may be involved in the development of 
leukaemia, it seems desirable and reasonable to complement the traditional anti-
microbial hygiene with ‘physical-chemical hygiene’, limiting environmental 
exposures to potential reactive agents as much as feasible.
Limited array of measures
In theory, the expected contribution to the number of cases of childhood 
leukaemia would be an important consideration in selecting the most promising 
measures. It was shown in the previous chapters, however, that for most factors 
no reliable estimate could be made. Moreover, in most cases not even the 
relationship itself has been scientifically proven.
Only where ionising radiation is concerned a causal relationship has been 
established. For benzene and paternal tobacco smoking such a relation is deemed 
to be likely, for pesticides it is considered possible to likely, while early social 
contacts and breast-feeding are likely protective factors. In all other cases, less 
certainty exists on the possible relation between an environmental influence and100 Childhood leukaemia and environmental factors
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Table 6. The likelihood of involvement of environmental risk factors in the causation of childhood leukaemia.
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childhood leukaemia, ranging from ‘possible’ in a number of cases to ‘uncertain’ 
or ‘unknown’ in others.
Another problem is that not every environmental factor can be influenced by 
policy measures. Cosmic radiation, for instance, is not something for which 
measures are practically available, except in the case of flying personnel during 
pregnancy. 
Still, several options present themselves when aiming for a reduction in the 
occurrence of childhood leukaemia. If avoiding exposures that are suspected to 
contribute to childhood leukaemia is a reasonable option, this should be 
contemplated, especially if measures to this effect could also protect against 
other adverse health effects. 
The situation with childhood leukaemia is characterised by uncertainty, 
complexity and ambiguity. Therefore it is warranted to take, as the Committee 
has done, a precautionary perspective to guide the risk assessment and 
subsequent risk management. 
The Committee suggests preventive measures when (a) plausible and 
relevant environmental risk factors of childhood leukaemia have been identified 
or (b) behavioural risk factors have been identified that are in line with existing 
recommendations given for other reasons, e.g. smoking and alcohol consumption 
during pregnancy. 
Three measures stand out because of their possible contribution to decreasing 
the number of cases of childhood leukaemia: reducing exposure of parents and 
children to ionising radiation, especially through medical applications; reducing 
Table 7. The likelihood of a protective influence of environmental factors in the occurrence of childhood leukaemia.
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occupational and residential exposure to pesticides and to benzene; and reducing 
parental tobacco smoking, also to reduce the risk of several other adverse health 
effects. Although considerable uncertainty still exists, the Committee considers it 
very likely that the contribution of these factors to the incidence of childhood 
leukaemia in high-risk groups might be substantial.
Reducing exposure to radiation
Medical radiation. Limiting the exposure to ionising radiation for medical 
purposes is important for both women in their (early) pregnancy and for children. 
In applying medical radiation, the risks always have to be justified and weighed 
against the advantages, but this is especially important where these two groups 
are concerned. The Committee feels that risk awareness in physicians can be 
improved. 
Applying optimisation and diagnostic reference levels is the way to achieve 
exposure reduction. Whenever possible, diagnostic techniques that do not 
involve ionising radiation should be used, such as ultrasound. However, this 
technique should also be used prudently: although a causal relation with limited 
exposures to routine ultrasound scans is considered unlikely, ultrasound scans 
should not be offered without medical indication. The Committee therefore sees 
a need for stricter justification standards and optimisation procedures for 
ultrasounds as well.
Other radiation sources. Where other radiation sources are concerned, the focus 
should also be on the reduction of exposure to as low as reasonably achievable 
(ALARA). This applies, for instance, to the emission of radioactive noble gases 
from nuclear facilities. These emissions should be monitored.
Reducing exposure to chemicals
Pesticides. Although uncertainty exists about the risks of occupational and 
residential use of pesticides, a reduction in the use of pesticides should be 
considered a priority. When using pesticides at home (i.c. biocides for pest 
control), risks and benefits should be carefully weighed. Especially women who 
want to become pregnant or who are already expecting should refrain from using 
pesticides, or should make sure they use extra protection measures. 
Other chemicals. The available evidence warrants taking measures to limit or 
prevent exposure of children and pregnant women to benzene and specific 
classes of other chemicals, such as PCBs.104 Childhood leukaemia and environmental factors
Reducing other environmental risks
Reducing environmental exposure to ELF magnetic fields, radon and chemicals. 
Precautionary measures are most obviously required for environmental factors 
that may possibly contribute to childhood leukaemia. Examples are limiting 
exposures to ELF magnetic fields from high-voltage power lines and, mainly for 
reasons other than childhood leukaemia, striving for a further reduction in 
exposures to radon from soil and building materials, as well as to specific 
chemicals such as formaldehyde, inorganic arsenic and plasticisers.
Avoiding parental smoking and consumption of alcohol and cured meat. For 
several parental lifestyle factors that have been linked with other diseases, 
considerable uncertainty exists where a causal relationship with childhood 
leukaemia is concerned. This applies to tobacco and marijuana smoking as well 
as to alcohol use. In these cases, a possible risk of leukaemia for the unborn child 
could provide an extra incentive to refrain from smoking and alcohol 
consumption when the conception of a child is intended. Although uncertainty 
exists about the evidence for a causal relation between parental intake of cured 
meat and childhood leukaemia, the Committee nevertheless recommends 
limiting the intake of nitrite-cured meat (e.g. ham, bacon and sausages) by 
pregnant women. 
Enhancing protective influences
Encouraging folic acid supplementation and breast-feeding. Some of the factors 
the Committee has studied may protect against childhood leukaemia, although 
once again considerable uncertainty exists. Folate supplementation before the 
intended conception and during early pregnancy is already recommended 
because of other beneficial effects, but may also reduce the risk of childhood 
leukaemia. The Committee therefore strongly supports this recommendation. 
The Committee also recommends to breastfeed children up to the age of 
approximately six months, whenever feasible, in line with the general 
recommendation. 
The importance of risk communication and public participation
Risk communication is the exchange of information and opinions between the 
authorities, the public and other parties involved, about the nature and extent of a 
risk.224 The message should be tailored to the needs of the receiver and must 
include clear information on what is known about the plausibility of potential 
health risks and the certain and uncertain effects of preventive measures. 
Different value judgements should be taken into account, and the risk 
communication should contribute to a balanced risk awareness. This can help Conclusion 105
people make informed choices. Any risk communication should also clarify that 
at a population level many factors may be shown to have an impact and that there 
is a complex interplay of causes; it will therefore never be possible to explain 
individual cases of leukaemia. 
As an important part of risk communication, the Committee recommends that 
women of childbearing age should be counselled, in order to create awareness of 
the risk of certain potentially harmful environmental and lifestyle factors 
previous to an intended conception.
Risk communication targeted at the general public or professionals can only 
be part of the approach. For medical radiation, risk awareness created by a risk 
communication programme can be a driving force in adopting new protocols and 
increasing the willingness to reduce exposure. Besides, implementation of 
measures is necessary, not only to reduce exposure to medical radiation, but also 
to radon, ELF magnetic fields and pesticides.
In conclusion, a number of factors discussed in this report have been shown 
to contribute to the risk of childhood leukaemia, or are likely to do so. Other 
factors carry only a small risk, or may turn out to be not involved at all. Despite 
this, people may worry, particularly in relation to locally observed clusters of 
childhood leukaemia, for instance around high voltage power lines. When 
concerns are raised, proper risk communication can help ensure that those 
involved are able to arrive at an informed opinion about risks that may be posed 
by local environmental factors. The involvement of residents at an early stage of 
risk assessment and risk management is a precondition for an effective policy to 
address local environmental health concerns or concerns of specific groups. 
Openness and transparency are key principles in this process. 
8.3 Research needs 
In identifying research needs, the expected contribution of a factor to the number 
of cases of childhood leukaemia should be the most important consideration, 
with exposure at the population level as the guiding principle. This means that 
studies need to focus on factors to which a large number of people are exposed or 
factors which greatly impact a smaller group. However, other considerations can 
play a role as well.
On the incidence of childhood leukaemia
Because of the relatively small numbers of childhood leukaemia cases per 
country, there is a need for international collaboration in studying variations in 
incidence in relation to variations in environmental exposures.
There is also a need for further research into why the peak in incidence 
occurs early in life. This might be associated with exposures during critical 
periods of differentiation.106 Childhood leukaemia and environmental factors
On genetic factors
Although insight into the genetic susceptibility of childhood leukaemia to risk 
factors is emerging, the interaction with environmental factors remains to be 
explored. A research question closely associated with that in the previous section 
concerns the causes that may explain the peak in incidence occurring early in life 
for genetic subtypes of ALL.
On environmental risk factors
In epidemiological research designs, the Committee recommends to pay more 
attention to the quality of exposure assessment and to specific leukaemia 
diagnoses (ALL/AML). In the analyses, specific attention needs to be paid to the 
most relevant exposure periods: before and during pregnancy, and in early 
childhood. Because of the differences in potential damage, it is important to 
differentiate, in research regarding the critical time windows of exposure during 
pregnancy, in ‘early’ (first 3-6 weeks), ‘mid’ and ‘late’ (last trimester). 
On combined exposures
Children and their parents are exposed to mixtures of different agents. However, 
hardly any study has looked into interactions, for instance between prenatal 
parental and postnatal environmental exposures. Therefore, the Committee 
recommends that, in epidemiological studies, more attention should be paid to 
the accumulation of risks of combined exposures.
On ionising radiation
A lot is known about the mechanism underlying the relation between leukaemia 
in children and the exposure to ionising radiation, but more research is still 
needed concerning the role of a number of specific exposure situations. Life has 
evolved under continuous exposure to natural ionising radiation, but due to the 
concentration of radioactive substances in building materials and high-altitude 
flights, and especially due to medical radiation, exposures have increased. More 
research into these types of exposures is therefore needed. 
Medical radiation. More detailed and precise data should be acquired on the 
exposure of unborn children and infants, including subgroups such as 
prematurely born children, in order to better apply justification of exposure and 
to apply dose reduction strategies for X-ray examinations. In addition, research is 
needed into the biological effects of pre- and postnatal diagnostic X-ray exposure 
in general and exposures from CT scans in particular.Conclusion 107
Residential proximity to nuclear installations. The Committee recommends to 
monitor the emissions of radioactive noble gases from nuclear installations, and 
to study locations that differ in the way emissions of radioactive noble gases are 
handled and locations in which accidental releases of radioactive noble gases 
have occurred. Also, it may be helpful to pool epidemiological data on all potential 
risk factors (i.e. not only those concerning ionising radiation) related to the vicinity 
of nuclear power plants on an international scale. 
Nuclear accidents. More research is also needed on the health effects, including 
non-cancer effects, of chronic internal exposures of children resulting from 
environmental contamination by radionuclides released during a nuclear 
accident.
On ultrasound scans
Ultrasound scans are offered to all pregnant women in the first and second 
trimester of pregnancy and are generally regarded as safe to the foetus. Current 
ultrasound technology, however, has a significantly higher output potential than 
the older machines used in most clinical studies. Ultrasound investigations 
during pregnancy are also commercially provided for non-medical purposes. 
More knowledge about the possible adverse effects of intensive and/or frequent 
ultrasound scans (e.g. following in vitro fertilisation, IVF) on leukaemia and 
other diseases is therefore needed.
On electromagnetic fields
More experimental research into possible carcinogenic mechanisms of extremely 
low frequency and radiofrequency electromagnetic fields is recommended.
On pesticides and other chemicals
The uncertainty about the leukaemic potential of different chemical 
environmental factors is large. So it is important to gain more insight into the 
possible contribution of separate factors to the occurrence of childhood 
leukaemia. 
Pesticides. The Committee recommends the monitoring of pesticide exposures 
among occupationally exposed women, at least of reproductive age, and to 
incorporate biomarkers of exposure in these studies, whenever feasible.
Benzene. In order to obtain more solid evidence on the causal relation between 
exposure to benzene and childhood leukaemia, targeted exposure monitoring 
studies should be performed.108 Childhood leukaemia and environmental factors
Other organic solvents. There is a need for both epidemiological and 
experimental studies into the relation between commonly encountered organic 
solvents and childhood leukaemia.
Cured meat. Nitrite is used in the curing of some types of meat. Because IARC 
classifies the consumption of nitrite as ‘probably carcinogenic to humans’, the 
Committee recommends targeted studies into a possible relation between cured 
meat ingestion during pregnancy and childhood leukaemia.
Other chemicals. Many other chemicals might, either separately or in 
combination with other factors, contribute to childhood leukaemia. Therefore 
targeted epidemiological studies should be performed on agents associated with 
an increase in chromosomal abnormalities or DNA abnormalities (gene 
mutations) in human blood cells, as these agents have access to and are active in 
human haematopoietic tissues. These studies should not only target pesticides 
and organic solvents, but also other potentially reactive or genotoxic chemicals, 
such as polychlorinated biphenyls (PCBs) and phthalates. 
On other risk factors
Since there is a lack of adequate data on a possible relation between infectious 
exposures and childhood leukaemia, research in this area is warranted, for 
instance into the space-time clustering of childhood leukaemia incidence in 
different populations. Finally, more research is required to obtain insight in the 
possible protective effect of vitamin supplementation during pregnancy on the 
risk for childhood leukaemia, in particular ALL.Conclusion 109
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C ALL/AML: CCG Evidence Summary
This annex contains summary tables of the evidence summary of the systematic 
review of reviews, performed by the Cochrane Childhood Cancer Group (CCG), 
in which ALL and AML were considered separately. 225
C.1 Physical risk factors
Ionising radiation
Table C1. Short summary of the selected systematic review on pre- and postnatal diagnostic X-rays a.226 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)
a The specific purpose of this review was to study the hypothesis that the association between prenatal and postnatal radiation 
exposure and childhood leukaemia would have become less strong, given technological improvements and the shift to non-
ionising imaging technologies (ultrasound). The authors concluded that their results might be interpreted as a confirmation 
of this hypothesis, underlining, however, that the results do not contradict previous evidence accumulated since 1956, 
indicating risk increases associated with prenatal X-ray exposure.
Pre- / postnatal 
diagnostic X-rays
Type of leukaemia Number of
pooled or individual 
studies
Results 
OR (95% CI) b
b OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis c 













6/9 (67%)ALL/AML: CCG Evidence Summary 131
Extremely low-frequency (ELF) magnetic fields
Table C2. Short summary of selected systematic review on residential proximity to nuclear facilities.227
 (A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)
Endpoint Type of leukaemia Number of pooled or 
individual studies
Results Quality of systematic 
review/meta-analysis a
a Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Living closer to 
nuclear facility
ALL 1 individual Higher risk b 
(significance level not 
stated)
b The conclusions in the ‘CCG Evidence Summary are based on one Swedish study, selected from the French review, as this 
was the only study that explicitly mentioned the type of leukaemia (ALL).228 There is a problem with this study as the 
conclusion of the reviewers in the original French research report (’Risque de leucémies pas plus élevé à proximité des sites 
qu’ailleurs’)129 differs from that published in an international journal in a special issue with the proceedings of a childhood 
leukaemia workshop (’Risk of leukaemia higher close to NPP than elsewhere’). It appears that the conclusion in the French 
research report is the correct one.
1/9 (11%)
Table C3. Short summary of selected systematic reviews on ELF magnetic fields.18,140 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)




Number of pooled or 
individual studies
Results 
OR/RR (95% CI) a




b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Residential magnetic fields:140
different definitions and 
subgroups c
c 24-hour or spot measurements in one or more rooms, wire-codes, distance and relative load for power lines, exposure from 
different electrical appliances, etc.
ALL > 2 individual (Non-) significant 
higher risks
1/10 (10%)
≥ 0.4 μT ALL Pooled (unclear nr) 2.1 (1.3–3.3)
Electric blankets:
prenatal use
ALL 1 individual 1.6 (1.1-2.3)
postnatal use ALL 2.8 (1.5-5.0)
Exposed to magnetic fields ≥0.4 
μT (as compared to <0.1 μT)18
ALL 1 individual 4.73 (1.14-19.7) 1/9 (11%)
AML 1 individual Risk not increased 
(no further 
information 
available)132 Childhood leukaemia and environmental factors
C.2 Chemical risk factors
Parental occupational exposure to pesticides
Residential exposure to pesticides
Arsenic exposure in drinking water
Table C4. Short summary of selected systematic review on parental occupational pesticide exposure.166
(A detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)
Parental occupational 
pesticide exposure






OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic review/ 
meta-analysis b




ALL 8 1.30 (0.86-1.95) 5/10 (50%)
AML 4 1.13 (0.59-2.14)
Maternal
(prenatal)
ALL 6 2.64 (1.40-5.0)
AML 4 2.64 (1.47-4.74)
Table C5. Short summary of selected systematic review on residential pesticide exposure.167





Number of combined or 
individual studies
Results
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
During pregnancy ALL 5 2.04 (1.54-2.68) 6/10 (60%)
AML 3 1.44 (0.81-2.59)
During childhood ALL 4 1.40 (0.90-2.16)
AML 2 1.71 (0.77-3.80)
Table C6. Short summary of selected systematic review on arsenic exposure in drinking water.195 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)




Number of combined or 
individual studies
Results Quality of systematic 
review/meta-analysis a 
a Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Prenatal ALL 1 individual Non-significantly 
lower risk
0/9 (0%)
Postnatal ALL 1 individual Non-significantly 




Table C7. Short summary of selected systematic review on parental tobacco smoking.198 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews225)




Number of pooled or 
individual studies
Results 
OR/RR (95% CI) a
a OR: odds ratio, RR: risk ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b 
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
From mother during 
pregnancy; several 
subgroupsc
c Number of cigarettes per day or any smoking.
ALL 6 individual Inconsistent 
results
2/11 (18%)
AML 2 individual Inconsistent 
results
From mother before 
pregnancy
ALL 1 individual 2.1 (1.0-4.3)
From father; several 
subgroups
ALL 4 pooled 1.17 (0.96-1.42)
AML 3 individual Inconsistent 
results
Table C8. Short summary of selected systematic review on parental marijuana smoking.201 





Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Maternal use during or in 
the year before pregnancy
AML 1 individual 11.0 (1.42-85.20) 1/9 (11%)
Paternal use AML 1 individual 1.47 (CI: not 
provided; p=0.32)
Table C9. Short summary of selected systematic review on parental alcohol consumption.202 





Number of pooled or 
individual studies
Results 
OR (95% CI) a
Quality of systematic 
review/meta-analysis b
Maternal alcohol consumption
Year before pregnancy ALL 1 individual 1.2 (0.9-1.5) 1/10 (10%)
Month prior to pregnancy ALL 2 individual Inconsistent results
AML 1 individual 1.8 (1-3.3)
During pregnancy; 
several subgroups c
ALL > 2 individual Inconsistent results
AML > 2 individual Inconsistent results134 Childhood leukaemia and environmental factors
C.3 Infectious agents and other factors
Different infectious exposures
During breast-feeding ALL 2 individual Inconsistent results
AML 1 individual 0.8 (0.3-1.9)
Paternal alcohol consumption
Month prior to 
conception; several 
subgroups
ALL > 2 individual Inconsistent results
AML > 2 individual Inconsistent results
Exposure period not 
stated
ALL 1 individual 1.2 (0.8-1.9)
One year prior to 
conception
AML 1 individual 1.5 (0.6-3.5)
a OR: odds ratio, CI: confidence interval.
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
c Prior to conception, first, second or third trimester, number of glasses, type of drinks.
Table C10. Short summary of selected systematic review on different infectious exposures.212 





Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b










ALL > 2 individual Inconsistent results
Different vaccinations ALL > 2 individual Inconsistent results
Birth order; several 
subgroups
ALL > 2 individual Inconsistent results
AML 1 individual 1.59 (1-2.53)
Paternal occupational  
social contact levels
ALL 1 individual 1.5 (1.1-2.1)ALL/AML: CCG Evidence Summary 135
Early social contacts
Allergies
Table C11. Short summary of selected systematic review on early social contacts.215 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)




Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Day-care attendance or social 
contacts; different definitions 
and subgroups c
c Day-care attendance, preschool playgroup, regular contact with children from outside home or social activities at different 
age or in different intensity.






d Most frequent type of ALL: common B-cell precursor ALL (cALL).
7 pooled 0.83 (0.70-0.98)
> 2 individual (Non-) 
significantly  
lower risks
Table C12. Short summary of selected systematic review on allergies.216 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)




Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic  
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Overall allergy ALL 8 pooled 0.67 (0.54-0.82) 5/11 (45%)
AML 3 individual Non-significantly 
lower risk
Asthma ALL 6 pooled 0.82 (0.63-1.10)
Hay fever ALL 5 pooled 0.53 (0.43-0.65)
Eczema ALL 5 pooled 0.68 (0.56-0.83)136 Childhood leukaemia and environmental factors
Breast-feeding
Maternal folate and vitamin supplementation
Table C13. Short summary of selected systematic review on breast-feeding.217 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)
Breast-feeding Type of 
leukaemia
Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Breast-feeding ALL 17 pooled 0.91 (0.84-0.98) 6/11 (55%)
AML   9 pooled 0.88 (0.76-1.02)
Duration of breast-feeding  
< 6 months
ALL 12 pooled 0.93 (0.86-1.00)
AML   8 pooled 0.97 (0.81-1.17)
Duration of breast-feeding  
> 6 months
ALL 13 pooled 0.81 (0.72-0.91)
AML   9 pooled 0.72 ( 0.57-0.91)
Table C14. Short summary of selected systematic review on maternal folate and vitamin supplementation.221 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)




Number of pooled or 
individual studies
Results 
OR (95% CI ) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Vitamins with folate versus no 
folate during pregnancy
ALL 2 pooled 1.06 (0.77-1.46) 1/11 (9%)
Vitamins with folate versus no 
vitamins during pregnancy
ALL 2 pooled 1.02 (0.86-1.21)
Vitamins before pregnancy ALL 2 pooled 0.95 (0.95-1.18)
Vitamins only before pregnancy ALL 2 pooled 1.05 (0.55-2.01)
Vitamins during pregnancy ALL 5 pooled 0.83 (0.73-0.94)
Folate before pregnancy ALL 1 individual 1.63 (0.55-4.82)ALL/AML: CCG Evidence Summary 137
Birth weight
Socio-economic status
Table C15. Short summary of selected systematic review on birth weight.222 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)
Birth weight Type of leukaemia Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
High birth weight 
compared to normal 
birth weight
ALL 23 pooled 1.24 (1.18-1.33) 2/11 (18%)
AML   9 pooled 1.24 (1.16-1.32)
Low birth weight ALL 10 pooled 0.97 (0.81-1.16)
AML   9 pooled 1.50 (1.05-2.13)
Per kilogram increase 
in birth weight
ALL 16 pooled 1.18 (1.12-1.23)
Table C16. Short summary of selected systematic review on socio-economic status.223 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.225)





Results Quality of systematic 
review/meta-analysis a
a Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Family income ALL 4 individual Inconsistent results 2/9 (22%)
AML 1 individual Higher AML rates 
significantly associated with a 
lower socioeconomic status
Mother’s education ALL 6 individual Inconsistent results
AML 1 individual Higher AML rates non-
significantly associated with a 
lower socioeconomic status
Father’s education ALL 4 individual Higher ALL rates (non-) 
significantly associated with a 
higher socioeconomic status
AML 2 individual Higher AML rates (non-) 
significantly associated with a 
lower socioeconomic status
Father’s occupational class ALL 2 individual Higher ALL rates non-
significantly associated with a 
higher socioeconomic status
Household density ALL 1 individual Higher ALL rates non-
significantly associated with a 
higher socioeconomic status
Derived measure (i.e. 
combining father’s 
education and occupation)
ALL 1 individual Higher ALL rates non-
significantly associated with a 
lower socioeconomic status
Ecological measures  
(i.e. both education and 
occupational class)
ALL 1 individual Higher ALL rates 
significantly associated with 
a higher socioeconomic 
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D Childhood leukaemia in general: 
Evidence Summary
This annex contains summary tables of the evidence summary of the systematic 
review of reviews in which childhood leukaemia in general was considered.213
D.1 Physical risk factors
Ionising radiation
Table D1. Short summary of the selected systematic review on pre- and postnatal diagnostic X-rays a. 226 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
a The purpose of this review was to study the hypothesis that the association between prenatal and postnatal radiation 
exposure and childhood leukaemia would have become less strong, given technological improvements and the shift to non-
ionising imaging technologies (ultrasound). The authors concluded that their results might be interpreted as a confirmation 
of this hypothesis, underlining, however, that the results do not contradict previous evidence accumulated since 1956, 
indicating risk increases associated with prenatal X-ray exposure.
Pre- / postnatal  
diagnostic X-rays
Number of
pooled or individual studies
Results 
OR / SIR / SMR (95% CI) b
b OR: odds ratio, SIR: standardized incidence ratio, SMR: standardized mortality ratio, CI: confidence interval.
Quality of systematic  
review/meta-analysis c
c Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Prenatal 9 pooled 0.99 (0.87-1.13) 8/10 (80%)
Postnatal 1 individual 1.29 (1.04-1.60)
3 individual Non-significant results
Table D2. Short summary of selected systematic review on residential proximity to nuclear facilities.227
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Endpoint Number of pooled or 
individual studies
Results Quality of systematic  
review/meta-analysis a
a Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Living closer to 
nuclear facility
25 individual No significance levels given 2/10 (20%)Childhood leukaemia in general: Evidence Summary 139
Extremely low-frequency (ELF) magnetic fields
Diagnostic ultrasound scans
D.2 Chemical risk factors
Parental occupational exposure to pesticides
Table D3. Short summary of selected systematic reviews on ELF magnetic fields.18,140
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Extremely low-frequency (ELF) 
magnetic fields 
Number of pooled or 
individual studies
Results 
OR/RR (95% CI) a
a OR: odds ratio, RR: risk ratio, CI: confidence interval.
Quality of systematic 
review/meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Residential magnetic fields:140
different types of studies, different 
definitions and subgroups c
c Prior to conception, first, second or third trimester, number of glasses, type of drinks.
22 individual (Non-)significant 
higher risks 
2/10 (20%)
≥0.4 μT 9 pooled 2.0 (1.3-3.1)
Electric blankets, pre- and  
postnatal use
3 individual Inconsistent results
Hair dryer 1 individual 2.8 (1.4-6.3)
Distance to transmission lines <49 m 
(as compared to > 600 m) 18
1 individual 1.67 1/10 (10%)
Exposure to magnetic fields ≥0.4 μT 
(as compared to <0.1 μT) 
1 individual 2.63 (0.77-8.96)
Table D4. Short summary of selected systematic reviews on diagnostic ultrasound scans.156
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Diagnostic ultrasound 
scans156
Number of pooled or 
individual studies
Results Quality of systematic review/
meta-analysis a




3 individual Neither higher or lower risk 3/10 (30%)
Table D5. Short summary of selected systematic review on parental occupational pesticide exposure.166
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Parental occupational 
pesticide exposure
Number of combined or 
individual studies
Results
OR (95% CI) a





- any pesticides 30 pooled 1.09 (0.88-1.34)
- insecticides   3 pooled 1.43 (1.06-1.92)
- herbicides   5 pooled 1.25 (0.94-1.66)140 Childhood leukaemia and environmental factors
Residential exposure to pesticides
Maternal cured meat intake
- fungicides    4 pooled 1.66 (0.87-3.17)
Maternal (prenatal)
- any pesticides 16 pooled 2.09 (1.51-2.88)
- insecticides   6 pooled 2.72 (1.47-5.04)
- herbicides   2 pooled 3.62 (1.28-10.3)
a OR: odds ratio, CI: confidence interval.
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Table D6. Short summary of selected systematic review on residential pesticide exposure.167
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Residential pesticide 
exposure
Number of combined or 
individual studies
Results
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic review/
meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
During pregnancy 8/11 (73%)
- unspecified 11 pooled 1.54 (1.13-2.11)
- insecticides   8 pooled 2.05 (1.80-2.32)
- herbicides   5 pooled 1.61 (1.20-2.16)
During childhood
- unspecified   9 pooled 1.38 (1.12-1.70)
- insecticides   7 pooled 1.61 (1.33-1.95)
- herbicides   4 pooled 0.96 (0.59-1.58)
Table D7. Short summary of selected systematic review on maternal cured meat intake.205 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Maternal cured meat 
intake
Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic review/
meta-analysis b
b Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Intake level 3 individual Non-significantly higher risk 4/10 (40%)
Meat type: 1 individual (no significance level given)
hotdogs 0.9
bacon & sausages 1.5
lunch meat 1.0
Ham 1.5Childhood leukaemia in general: Evidence Summary 141
D.3 Infectious agents and other factors
Different infectious exposures
Socio-economic status
Table D8. Short summary of selected systematic review on different infectious exposures.212 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Different infectious 
exposures
Number of pooled or 
individual studies
Results 
OR (95% CI) a
a OR: odds ratio, CI: confidence interval.
Quality of systematic  
review/meta-analysis b




> 2 individual (Non-) significantly higher risks
Different childhood 
infections
> 2 individual Inconsistent (non) significant results
Different vaccinations > 2 individual Non-significant results, except for 
significant lower risk for 
‘immunisations’
Birth order; several 
subgroups
> 2 individual Conflicting results
Paternal occupational 
social contact levels
> 2 individual Inconsistent results
Table D9. Short summary of selected systematic review on socio-economic status.223 
(A more detailed summary is presented in the original CCG Evidence summary of systematic reviews.213)
Socioeconomic status Number of pooled or 
individual studies
Results Quality of systematic  
review/meta-analysis a
a Methodological quality of systematic review/meta-analysis, i.e. total number of criteria scored as yes out of applicable 
criteria.
Family income 1 individual Non-significant higher risk 3/10 (30%)
4 individual Significant lower risks
3 individual Non-significant lower risks
Mother’s education 2 individual Significant higher risks
4 individual Non-significant higher risks
5 individual Significant lower risks
2 individual Non-significant lower risks
Father’s education 2 individual Non-significant higher risks
4 individual Significant lower risks
3 individual Non-significant lower risks
Father’s occupational class 3 individual Significant higher risks
5 individual Non-significant higher risks
1 individual Significant lower risk
2 individual Non-significant lower risks
Household density 1 individual Significant higher risk
1 individual Non-significant higher risk
1 individual Non-significant lower risk
Derived measure (i.e. combining 
father’s education and 
occupation)
1 individual Non-significant lower risk
Highest parental education 3 individual Inconsistent results142 Childhood leukaemia and environmental factors
E Causality considerations and 
limitations
The Committee has focussed in this report on epidemiological studies. In such 
observational studies the quality of exposure assessment is crucial, especially in 
deriving dose response relations.229 Moreover, the reduction of bias and the 
adjustment for confounding factors are important in assessing the evidence for 
causality of associations. The data presented in chapters 4-6 show that some 
associations have been found, but these cannot be taken as proof of causality. 
One standard tool in assessing evidence for causality are Bradford Hill’s 
considerations: strength, consistency, specificity, temporality, biological gradient 
(or exposure-response), plausibility, coherence, experiment, analogy.14,15 
E.1 The Bradford Hill considerations
Bradford Hill emphasised that none of the following nine considerations can 
bring indisputable evidence for or against the cause-and-effect hypothesis and 
none can be required as a sine qua non. So, absence does not disprove causality, 
only presence is considered a contributing argument that causality exists.
Strength
A relative risk or odds ratio higher than 2 would usually be considered a 
relatively strong association. However, few environmental risk factors of disease 
reach such values. Also as there is often substantial misclassification of 
exposure, this mostly leads to underestimation of the real risk, thus decreasing 
the strength. In this report most of the relative risks and odds ratios are too low  
(< 2-3) to be considered as contributing to the strength argument. 
Consistency
Consistency of results from different studies strengthens the causality argument. 
However, different exposure situations are often not identical, which makes it 
very hard for environmental causes to fulfil this criterion. In this report most of 
the evidence for individual exposures comes from a limited number of studies. 
As in the previous consideration, the absence of consistency does not disprove 
causality, the argument is just not strengthened.Causality considerations and limitations 143
Specificity
Specificity of outcome means that the exposure is not associated with different 
adverse outcomes. The literature evaluated in this report is often focussed on 
childhood leukaemia and other diseases/outcomes are usually not considered. 
This does not mean that other outcomes do not occur, the information on that is 
simply not available. However, in general specificity is one of the weakest 
considerations, as it very rarely the case that only one carcinogen causes disease.
Temporality
Risk factors for childhood leukaemia can mostly only be investigated in case-
control studies. This means that exposure is measured retrospectively, so 
temporality can never truly be addressed like in prospective cohort studies. This 
is a considerable problem, as temporality is a crucial consideration. A potential 
cause cannot be an actual cause if the exposure occurred after the disease 
developed. It should be noted that various biases in case-control studies, such as 
responder and recall bias, might influence the recall of timing of exposure. 
Ultimately only prospective cohort studies can solve this, but these are rare in the 
collection of investigations reviewed in this report.
Biological gradient or exposure-response
Exposure-response relationships can only be assessed if exposure can be 
measured adequately and with sufficient precision.229 However, since often only 
the use of questionnaires or at best spot-sampling are available methods, 
exposure assessment is difficult and often also done poorly. 
A complicating factor with childhood leukaemia is that exposure can occur at 
different phases in the development of a child: before, during and after 
pregnancy. Exposure of the parent to environmental factors before conception or 
during the pregnancy may both related to genetic or epigenetic damage, the latter 
for instance by enhanced proliferation of cells.230 Effects of exposure at an early 
stage of pregnancy may differ from exposure at a later stage and from postnatal 
exposure. 
Another problem is that in practice children and their parents are exposed to 
mixtures of different agents, but there is hardly any study performed on 
interactions, not only of agents, but also between prenatal and postnatal 
exposures.
Plausibility
This refers to the understanding of the biological model behind the causality of 
the exposures in questions. If there is information available, the argument for 144 Childhood leukaemia and environmental factors
causality is strengthened, but for many suspected carcinogens the quantitative 
details of biological model are unknown. 
Coherence
This argument means that the cause and effect interpretation should not seriously 
conflict with the generally known facts of the natural history and biology of the 
disease. However, as in reality little is known about the natural history of 
childhood leukaemias besides their clinical features, it is not a useful 
consideration in the framework of this report.
Experiment
Data from experimental studies, showing evidence for effects, may strengthen 
the biological plausibility of an association. Of course for childhood leukaemia 
only animal experiments are acceptable. However, the question is whether the 
animals used (mostly rodents) are an adequate model for humans and how the 
doses given to the animals are comparable to doses in humans. For exposure 
around pregnancy the timing of the exposure may well be different also.
Analogy
According to Bradford Hill, it would in some circumstances be fair to judge by 
analogy. This means that if it is known that the effect of one type of exposure can 
lead to childhood leukaemia, a similar effect from another type of exposure 
might also. However, the variety of types of exposure addressed in this report is 
so wide and so little is known about these exposures, that analogy is not a very 
useful consideration in practice.
E.2 Chance, bias and confounding
In addition to the Bradford Hill considerations and the strength of evidence, 
alternative explanations for epidemiological associations other than causality 
should be considered: chance, bias (specifically exposure misclassification) and 
confounding. If these are unlikely, a causal relation is more likely. In particular in 
situations of sparse epidemiological evidence and a lack of information on these 
factors, judgements about the causal nature of reported associations between 
exposures and childhood leukaemia have to be made with caution.Causality considerations and limitations 145
Chance
If associations are observed in epidemiological studies, it needs to be determined 
whether they can be explained by either chance or a particular cause. By 
definition there is a five-percent likelihood that a ‘statistically significant’ 
association will be found that can be attributed to chance (a ‘false positive’). If 
several statistical tests (multiple comparisons) are made, a ‘statistically 
significant’ association will be attributable to coincidence in one in twenty tests. 
On the other hand, not finding an association can also be a chance finding (a 
‘false negative’).
Bias
Effect measured in epidemiological studies can be biased in three ways: through 
selection bias, information bias or confounding.10 They differ for different types 
of studies, such as cohort and case-control studies. 
Selection bias. Selection bias may occur as a result of the way the study 
population is selected. In case-control studies, participants enter the study based 
on being ill (cases) or explicitly not having the disease of interest (controls). The 
selection that occurs at the start of the study can already bias the results. In some 
studies the selection of both cases and controls is conducted within one or several 
hospitals. However, the patterns of hospital admission can be different for 
different diseases. For instance, if the hospital is the only possible treatment 
facility for cancer in the region but there are many smaller hospitals for e.g. 
emergencies, the hospital treating cancer will cater for different populations for 
the cancer patients than for its emergency ward patients. If the controls are 
recruited from the latter groups, the cases and controls are drawn from different 
populations that might not be comparable. Population-based case-control studies 
suffer less from this selection bias, but in these studies it needs to be clear that the 
controls are truly representative for the same community as the cases.231
Response rates in case-control studies need to be high enough for the study 
population to be representative of the population it stems from, ideally at least 
70%, and they also need to be sufficiently similar between cases and controls.
Information bias. Information bias can occur through misclassification of health 
effects as well as through misclassification of the exposure. 
Misclassification of effect. Misclassification of effects may, for example, occur 
as the result of differences in reporting, diagnostics, registration, coding, 
admission and treatment policy, or availability and accessibility of health care. 146 Childhood leukaemia and environmental factors
Misclassification of exposure. Quantification of exposure is almost always very 
crude and this lack of precision leads to a flattening of the exposure-response 
curve.232 Misclassification can also occur if the exposure occurred many years 
before the health effects, making it difficult to measure the exposure in question. 
If the misclassification of the exposure occurs proportionally in the case and 
control population, the result generally underestimating the risk.233 
Reduction of information bias: blinding. In case-control studies it is impossible 
to blind the cases for the diagnosis. Once diagnosed, patients will search for 
explanations of their illness. They are likely to report their past exposure for any 
potential cause differently from controls who do not have this incentive. As 
patients are often clearly ill, it is also virtually impossible to blind interviewers 
for the disease status, thus allowing for suggestive interviewing in either 
direction. Blinding the observers through the use of mailed-in or web-based 
questionnaires is the only way to control this. Even telephone interviews are 
often not blinded, as patients are likely to reveal their disease status.231
Confounding
Health status depends on many factors, including age, sex, level of urbanisation, 
socio-economic status, ethnicity, smoking habits and other lifestyle factors. 
Availability of health services can also affect the health status. The effect of these 
factors may differ considerably from one situation to another, which increases 
the risk of confounding the study on the relationship between environmental 
exposure and disease, especially if associations are weak. 
A confounding factor is described as a known risk factor that is associated 
with the exposure being studied, but that is not an intermediary factor in the 
causal relationship between exposure and effect.10 If there are sufficient data on 
relevant risk factors, it is possible to adjust for confounding. They need to be 
controlled for and thus measured. Age, sex, social-economic status and education 
are common confounders, but other factors are also possible. Matching of cases 
and controls can be a way to control confounding, but in some cases can 
introduce confounding also, so over-matching should be avoided.231 Causality considerations and limitations 147
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F Classifications of evidence
IARC-classification of scientific evidence
To characterise the strength of evidence for a causal relation between exposure to 
environmental factors and cancer IARC16 developed a classification based on: 
• Epidemiological evidence 
• Animal experimental evidence and 
• Mechanistic and other evidence. 
The evidence from studies in humans and experimental animals is classified into 
one of the following categories:
• Sufficient evidence of carcinogenity
• Limited evidence of carcinogenity
• Inadequate evidence of carcinogenity
• Evidence suggesting lack of carcinogenity.
Together with the available mechanistic and other evidence the body of evidence 
is considered as a whole, in order to reach an overall evaluation of the 
carcinogenity of the agent to humans. The following categories are 
distuinguished:
• Group 1: the agent is carcinogenic to humans
• Group 2A: the agent is probably carcinogenic to humans
• Group 2B: the agent is possibly carcinogenic to humans
• Group 3: the agent is not classifiable as to its carcinogenicity to humans
• Group 4: the agent is probably not carcinogenic to humans.
This classification cannot as such be used in the present report, since 
experimental and mechanistic evidence is not considered in detail.
Wigle-classification of epidemiological evidence
Wigle expressed the IARC-classification of epidemiological evidence for causal 
relationships between child health outcomes and environmental chemical 
contaminants as three ‘levels of evidence’: sufficient, limited or inadequate, 
according to predefined criteria of the U.S. National Academy of Sciences (Table 
F1).17Classifications of evidence 149




Sufficient At least one expert group has reviewed the available evidence and published a peer-reviewed report 
indicating a consensus view that there is a causal relationship.
Limited Limited evidence is suggestive of an association between the agent and the outcome but is limited (and 
may or may not represent a causal relationship) because chance, bias and confounding cannot be ruled out 
with confidence, e.g. at least one high quality study shows a positive association but the results of other 
studies are inconsistent. 
Inadequate Available studies are of insufficient quality (e.g. available studies have failed to adequately control for 
confounding or have inadequate exposure assessment), consistency or statistical power to permit a 
conclusion regarding the presence or absence of an association or no studies exist that examine the 
relationship.150 Childhood leukaemia and environmental factors
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advisory reports based on the highest level of scientific expertise available whilst 
maintaining all possible impartiality.
The advisory reports drawn up by the working groups are submitted to the 
Board. Once they have been endorsed, they are sent to those who requested them 
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the current level of knowledge with respect to public health issues and health 
(services) research...” (Section 22, Health Act).
The Health Council receives most requests for advice from the Ministers of 
Health, Welfare & Sport, Infrastructure & the Environment, Social Affairs & 
Employment, Economic Affairs, and Education, Culture & Science. The Council 
can publish advisory reports on its own initiative. It usually does this in order to 
ask attention for developments or trends that are thought to be relevant to 
government policy.
Most Health Council reports are prepared by multidisciplinary committees of 
Dutch or, sometimes, foreign experts, appointed in a personal capacity. The 
reports are available to the public.
Members of Health Council Committees are appointed in a personal capacity 
because of their special expertise in the matters to be addressed. Nonetheless, it 
is precisely because of this expertise that they may also have interests. This in 
itself does not necessarily present an obstacle for membership of a Health 
Council Committee. Transparency regarding possible conflicts of interest is 
nonetheless important, both for the chairperson and members of a Committee 
and for the President of the Health Council. On being invited to join a 
Committee, members are asked to submit a form detailing the functions they 
hold and any other material and immaterial interests which could be relevant for 
the Committee’s work. It is the responsibility of the President of the Health 
Council to assess whether the interests indicated constitute grounds for non-
appointment. An advisorship will then sometimes make it possible to exploit the 
expertise of the specialist involved. During the inaugural meeting the 
declarations issued are discussed, so that all members of the Committee are 
aware of each other’s possible interests.
The EuSANH-ISA project is supported by funding under the Seventh 
Framework Programme of the European Conmmunity under grant 
agreement number 229716.155
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